| American College of Mohs Surgery | 79.0 | 3 | 2 |
| Medicare Advantage | 68.9 | 3 | 1 |
| Medigap Seminars. | 68.9 | 3 | 1 |
| WATER'S EDGE DERMATOLOGY | 68.3 | 2 | 2 |
| Mayo Clinic | 60.0 | 4 | 0 |
| University of Texas Southwestern Medical Center | 60.0 | 4 | 0 |
| Structuring integration for patient-centered care: a review-informed ontology-driven modular front-end framework for digital health innovation | 58.2 | 2 | 1 |
| National Institute for Occupational Safety and Health | 51.7 | 3 | 0 |
| Q229883 | 51.7 | 3 | 0 |
| United States National Institutes of Health | 51.7 | 3 | 0 |
| Vital and health statistics. Series 21, Data on natality, marriage, and divorce | 51.7 | 3 | 0 |
| Vital and health statistics. Series 5, Comparative international vital and health statistics reports | 51.7 | 3 | 0 |
| Harvard men's health watch | 51.7 | 3 | 0 |
| Harvard women's health watch | 51.7 | 3 | 0 |
| BayCare Health System | 51.7 | 3 | 0 |
| Office of Readiness and Response | 51.7 | 3 | 0 |
| Skin Cancer Foundation | 43.1 | 1 | 1 |
| Associated Skin Care Specialists | 43.1 | 1 | 1 |
| American Society for Dermatologic Surgery | 43.1 | 1 | 1 |
| Schweiger Dermatology Group (United States) | 43.1 | 1 | 1 |
| Massachusetts General Hospital | 41.0 | 2 | 0 |
| Nucleic Acids Research | 41.0 | 2 | 0 |
| National Cancer Institute | 41.0 | 2 | 0 |
| U.S. News & World Report | 41.0 | 2 | 0 |
| The University of Texas MD Anderson Cancer Center | 41.0 | 2 | 0 |
| Epi Info | 41.0 | 2 | 0 |
| Rusk Institute of Rehabilitation Medicine | 41.0 | 2 | 0 |
| Cleveland Clinic | 41.0 | 2 | 0 |
| American Family Physician | 41.0 | 2 | 0 |
| American Journal of Translational Research | 41.0 | 2 | 0 |
| Biomedical Optics Express | 41.0 | 2 | 0 |
| dbSNP | 41.0 | 2 | 0 |
| Duke University Health System | 41.0 | 2 | 0 |
| Northwell Health | 41.0 | 2 | 0 |
| Preventing Chronic Disease | 41.0 | 2 | 0 |
| Western Journal of Medicine | 41.0 | 2 | 0 |
| Trends in Amplification | 41.0 | 2 | 0 |
| Trustpilot | 41.0 | 2 | 0 |
| Ulster Medical Journal | 41.0 | 2 | 0 |
| Michigan Medicine | 41.0 | 2 | 0 |
| University of Pittsburgh Medical Center | 41.0 | 2 | 0 |
| UpToDate | 41.0 | 2 | 0 |
| Allegheny Health Network | 41.0 | 2 | 0 |
| The AAPS Journal | 41.0 | 2 | 0 |
| Rice | 41.0 | 2 | 0 |
| AAPS PharmSciTech | 41.0 | 2 | 0 |
| International Journal of Mental Health Systems | 41.0 | 2 | 0 |
| Journal of Urban Health | 41.0 | 2 | 0 |
| Neural Development | 41.0 | 2 | 0 |
| Journal of the Society of Laparoendoscopic Surgeons | 41.0 | 2 | 0 |
| National Health Service | 41.0 | 2 | 0 |
| HealthGrades | 41.0 | 2 | 0 |
| National Survey of Family Growth | 41.0 | 2 | 0 |
| National Vital Statistics System | 41.0 | 2 | 0 |
| NIOSH Power Tools Database | 41.0 | 2 | 0 |
| UCLA Health System | 41.0 | 2 | 0 |
| Q20641742 | 41.0 | 2 | 0 |
| Luton and Dunstable University Hospital NHS Foundation Trust | 41.0 | 2 | 0 |
| Morbidity and Mortality Weekly Report: Recommendations and Reports | 41.0 | 2 | 0 |
| Joseph John Klimek | 41.0 | 2 | 0 |
| Baptist Health South Florida | 41.0 | 2 | 0 |
| The Journal of clinical and aesthetic dermatology | 41.0 | 2 | 0 |
| Alcohol research : current reviews | 41.0 | 2 | 0 |
| Vital & health statistics. Series 3, Analytical and epidemiological studies | 41.0 | 2 | 0 |
| Dermato-endocrinology | 41.0 | 2 | 0 |
| British Heart Journal | 41.0 | 2 | 0 |
| The western journal of emergency medicine | 41.0 | 2 | 0 |
| Psychiatry | 41.0 | 2 | 0 |
| Mycobiology | 41.0 | 2 | 0 |
| Vital and health statistics. Series 3, Analytical studies | 41.0 | 2 | 0 |
| Vital and health statistics. Ser. 4, Documents and committee reports | 41.0 | 2 | 0 |
| Vital and health statistics. Series 13, Data from the National Health Survey | 41.0 | 2 | 0 |
| The Harvard mental health letter | 41.0 | 2 | 0 |
| Aging trends (Hyattsville, Md.) | 41.0 | 2 | 0 |
| NCHS data brief | 41.0 | 2 | 0 |
| MMWR supplements | 41.0 | 2 | 0 |
| U.S. News & World Report Best Colleges Ranking | 41.0 | 2 | 0 |
| National Center for Emerging and Zoonotic Infectious Diseases | 41.0 | 2 | 0 |
| Division of Parasitic Diseases and Malaria | 41.0 | 2 | 0 |
| Boscombe Community Hospital | 41.0 | 2 | 0 |
| Advanced Dermatology & Cosmetic Surgery | 41.0 | 2 | 0 |
| Chronic Disease Prevention and Health Promotion | 41.0 | 2 | 0 |
| UPMC Health System | 41.0 | 2 | 0 |
| University of Miami Health System | 41.0 | 2 | 0 |
| WellSpan Ephrata Community Hospital | 41.0 | 2 | 0 |
| Syosset Hospital | 41.0 | 2 | 0 |
| Johns Hopkins Medicine | 41.0 | 2 | 0 |
| AACR Award for Lifetime Achievement in Cancer Research | 41.0 | 2 | 0 |
| University of Utah Health Care | 41.0 | 2 | 0 |
| AACR-G.H.A. Clowes Award for Outstanding Basic Cancer Research | 41.0 | 2 | 0 |
| Topical Treatment of Basal Cell Carcinoma with the Immune Response Modifier Imiquimod | 40.0 | 0 | 4 |
| Treatment of Basal Cell Carcinoma in the Elderly: What Nondermatologists Need to Know | 40.0 | 0 | 4 |
| An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis. | 40.0 | 0 | 4 |
| Mohs Surgery versus Standard Local Excision for Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Skin Cancer | 40.0 | 0 | 4 |
| Erratum: Mohs Surgery versus Standard Local Excision for Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Skin Cancer | 40.0 | 0 | 4 |
| skin cancer | 34.5 | 0 | 3 |
| Advances in Wound Care | 34.5 | 0 | 3 |
| Guidelines for the management of squamous cell carcinoma in organ transplant recipients | 34.5 | 0 | 3 |
| Management of benign skin lesions commonly affecting the face: actinic keratosis, seborrheic keratosis, and rosacea | 34.5 | 0 | 3 |
| Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group | 34.5 | 0 | 3 |
| Melanoma screening by means of complete skin exams for all patients in a dermatology practice reduces the thickness of primary melanomas at diagnosis | 34.5 | 0 | 3 |
| Skin Cancer Epidemiology, Detection, and Management | 34.5 | 0 | 3 |
| Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods | 34.5 | 0 | 3 |
| Association of CRR9 locus with elevated risk of squamous cell carcinoma and basal cell carcinoma | 34.5 | 0 | 3 |
| Trends in Non-Melanoma Skin Cancer (Basal Cell Carcinoma and Squamous Cell Carcinoma) in Canada: A Descriptive Analysis of Available Data | 34.5 | 0 | 3 |
| Evaluation of prospectively collected presenting signs/symptoms of biopsy-proven melanoma, basal cell carcinoma, squamous cell carcinoma, and seborrheic keratosis in an elderly male population | 34.5 | 0 | 3 |
| Pattern of Nonmelanoma Skin Cancers in Sikkim, India: A 3-year Clinicopathological Review | 34.5 | 0 | 3 |
| Confocal microscopy patterns in nonmelanoma skin cancer and clinical applications | 34.5 | 0 | 3 |
| Squamous Cell Carcinoma in-situ and Basal Cell Carcinoma Arising From Seborrheic Keratosis in the Same Patient | 34.5 | 0 | 3 |
| A 10-year review of outpatient skin biopsy results and skin cancer subtypes | 34.5 | 0 | 3 |
| Skin Cancer (Basal Cell Carcinoma, Squamous Cell Carcinoma, and Malignant Melanoma): New Cases, Treatment Practice, and Health Care Costs in New Brunswick, Canada, 2002–2010 | 34.5 | 0 | 3 |
| Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma | 34.5 | 0 | 3 |
| Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma. | 34.5 | 0 | 3 |
| Dermal changes in superficial basal cell carcinoma, melanoma in situ and actinic keratosis and their implications | 34.5 | 0 | 3 |
| Histophotometric investigation of the nuclear DNA-content in normal epidermis, seborrheic keratosis, keratosis senilis, squamous cell carcinoma and basal cell carcinoma | 34.5 | 0 | 3 |
| Multiple actinic keratosis, squamous cell carcinoma and basal cell carcinoma occurred after PUVA therapy in a Korean patient | 34.5 | 0 | 3 |
| Cutaneous vitamin A levels in seborrheic keratosis, actinic keratosis, and basal cell carcinoma | 34.5 | 0 | 3 |
| Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group | 34.5 | 0 | 3 |
| Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma. | 34.5 | 0 | 3 |
| The big three of skin cancer: basal cell carcinoma, squamous cell carcinoma, and malignant melanoma | 34.5 | 0 | 3 |
| Multiple skin cancers in a single patient: Multiple pigmented Bowen's disease, giant basal cell carcinoma, squamous cell carcinoma | 34.5 | 0 | 3 |
| Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis | 34.5 | 0 | 3 |
| The expression of p53 and cox-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases | 34.5 | 0 | 3 |
| Geographic variation and risk of skin cancer in US women. Differences between melanoma, squamous cell carcinoma, and basal cell carcinoma | 34.5 | 0 | 3 |
| Quantitative assessment of Langerhans cells in actinic keratosis, Bowen's disease, keratoacanthoma, squamous cell carcinoma and basal cell carcinoma | 34.5 | 0 | 3 |
| Non-melanoma skin cancer : Pathogenesis, prevalence and prevention | 34.5 | 0 | 3 |
| Focal adhesion kinase and Src expression in premalignant and malignant skin lesions | 34.5 | 0 | 3 |
| Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults | 34.5 | 0 | 3 |
| Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer | 34.5 | 0 | 3 |
| Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides | 34.5 | 0 | 3 |
| Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer | 34.5 | 0 | 3 |
| Buddy Relationships in DermatoloGic Excisions for Skin Cancer | 34.5 | 0 | 3 |
| DNA repair synthesis in fibroblast strains from patients with actinic keratosis, squamous cell carcinoma, basal cell carcinoma, or malignant melanoma after treatment with ultraviolet light, N-acetoxy-2-acetyl-aminofluorene, methyl methanesulfonate, | 34.5 | 0 | 3 |
| The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma | 34.5 | 0 | 3 |
| Facing skin cancer surgery. Mohs surgery may be your best option for nonmelanoma skin cancers | 34.5 | 0 | 3 |
| Photodynamic Therapy in Treating Patients With Skin Cancer (1993-11-30) | 34.5 | 0 | 3 |
| Non-melanoma Skin Cancer - a Clinicopathological Study of Patients with Basal Cell Carcinoma and Squamous Cell Carcinoma | 34.5 | 0 | 3 |
| Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study | 34.5 | 0 | 3 |
| Digital ex-vivo confocal imaging for fast Mohs surgery in nonmelanoma skin cancers: An emerging technique in dermatologic surgery | 34.5 | 0 | 3 |
| Nonmelanoma skin cancer - from actinic keratosis to cutaneous squamous cell carcinoma | 34.5 | 0 | 3 |
| Association between Blood Group and Nonmelanoma Skin Cancers (Basal Cell Carcinoma and Squamous Cell Carcinoma) | 34.5 | 0 | 3 |
| Basal cell carcinoma, squamous cell carcinoma and premalignant skin lesions--how to treat? | 34.5 | 0 | 3 |
| Comparison and evaluation of three different molecular methods for detection of human Betapapillomaviruses in skin biopsies from patients with nonmelanoma skin cancer and precancerous lesions | 34.5 | 0 | 3 |
| P267 Evaluation of the role of human papillomavirus in actinic keratosis, seborrheic keratosis, basal cell carcinoma and squamous carcinoma | 34.5 | 0 | 3 |
| Q135335149 | 34.5 | 0 | 3 |
| rash | 27.3 | 0 | 2 |
| basal-cell carcinoma of the skin | 27.3 | 0 | 2 |
| La Roche-Posay | 27.3 | 0 | 2 |
| Mohs surgery | 27.3 | 0 | 2 |
| Category:Skin cancer | 27.3 | 0 | 2 |
| diabetic dermadrome | 27.3 | 0 | 2 |
| cutaneous squamous-cell carcinoma | 27.3 | 0 | 2 |
| pathergy | 27.3 | 0 | 2 |
| skin biopsy | 27.3 | 0 | 2 |
| Template:Skin lesion terminology | 27.3 | 0 | 2 |
| Advances in Skin and Wound Care | 27.3 | 0 | 2 |
| Dermatologic Surgery | 27.3 | 0 | 2 |
| No7 product line | 27.3 | 0 | 2 |
| E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice | 27.3 | 0 | 2 |
| Review of photodynamic therapy in actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Fernblock (Polypodium leucotomos Extract): Molecular Mechanisms and Pleiotropic Effects in Light-Related Skin Conditions, Photoaging and Skin Cancers, a Review | 27.3 | 0 | 2 |
| Novel treatment options for nonmelanoma skin cancer: focus on electronic brachytherapy | 27.3 | 0 | 2 |
| Targeted Therapy for Orbital and Periocular Basal Cell Carcinoma and Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Point of care cutaneous imaging technology in melanoma screening and mole mapping | 27.3 | 0 | 2 |
| The Journal of dermatologic surgery and oncology | 27.3 | 0 | 2 |
| Advances in wound care : the journal for prevention and healing | 27.3 | 0 | 2 |
| Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face | 27.3 | 0 | 2 |
| Dermoscopic differentiation of a superficial basal cell carcinoma and squamous cell carcinoma in situ | 27.3 | 0 | 2 |
| Q28274622 | 27.3 | 0 | 2 |
| Ingenol Disoxate: A Novel 4-Isoxazolecarboxylate Ester of Ingenol with Improved Properties for Treatment of Actinic Keratosis and Other Non-Melanoma Skin Cancers | 27.3 | 0 | 2 |
| Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Long Island Skin Cancer and Dermatologic Surgery | 27.3 | 0 | 2 |
| Basal cell carcinoma vs basaloid squamous cell carcinoma of the skin: an immunohistochemical reappraisal. | 27.3 | 0 | 2 |
| XRCC3 C18067T Polymorphism Contributes a Decreased Risk to Both Basal Cell Carcinoma and Squamous Cell Carcinoma: Evidence from a Meta-Analysis | 27.3 | 0 | 2 |
| Nasal cavity squamous cell carcinoma presenting as a nasal sidewall nodule: treatment with Mohs surgery, partial rhinectomy, and adjuvant radiotherapy | 27.3 | 0 | 2 |
| Lasers and cosmetic dermatologic surgery for aging skin | 27.3 | 0 | 2 |
| Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-97. | 27.3 | 0 | 2 |
| Diagnostic and neural analysis of skin cancer (DANAOS). A multicentre study for collection and computer-aided analysis of data from pigmented skin lesions using digital dermoscopy. | 27.3 | 0 | 2 |
| The risk of non-melanoma skin cancer in HIV-infected patients: new data and meta-analysis | 27.3 | 0 | 2 |
| Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study. | 27.3 | 0 | 2 |
| High frequency of human papillomavirus 6/11, 16, and 18 infections in precancerous lesions and squamous cell carcinoma of the conjunctiva in subtropical Tanzania | 27.3 | 0 | 2 |
| Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ With a High-Energy Pulsed Carbon Dioxide Laser | 27.3 | 0 | 2 |
| Use of ex vivo confocal scanning laser microscopy during Mohs surgery for nonmelanoma skin cancers | 27.3 | 0 | 2 |
| Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: follow-up data from the Nambour Skin Cancer Prevention Trial | 27.3 | 0 | 2 |
| Actinic keratoses, basal cell carcinoma, and squamous cell carcinoma: uncommon treatments | 27.3 | 0 | 2 |
| Photodynamic therapy for 50 patients with skin cancers or precancerous lesions | 27.3 | 0 | 2 |
| Heat shock protein 105 is overexpressed in squamous cell carcinoma and extramammary Paget disease but not in basal cell carcinoma | 27.3 | 0 | 2 |
| The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review | 27.3 | 0 | 2 |
| Histologic comparison of canine skin biopsies collected using monopolar electrosurgery, CO2 laser, radiowave radiosurgery, skin biopsy punch, and scalpel | 27.3 | 0 | 2 |
| Current recommendations in the treatment of basal cell carcinoma and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Imiquimod: an immune response modifier in the treatment of precancerous skin lesions and skin cancer | 27.3 | 0 | 2 |
| The actinic keratosis virome: can we prevent squamous cell carcinoma with a vaccine? | 27.3 | 0 | 2 |
| Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data | 27.3 | 0 | 2 |
| Should variation of serum lipid levels be considered a risk factor for the development of basal cell carcinoma? | 27.3 | 0 | 2 |
| Expression of Cold-Inducible RNA-Binding Protein in Normal Skin, Actinic Keratosis and Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| A case of cutaneous squamous cell carcinoma arising in an actinic keratosis on the face in a centenarian woman successfully treated with surgery | 27.3 | 0 | 2 |
| Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). | 27.3 | 0 | 2 |
| Squamous cell carcinoma, not basal cell carcinoma, is the most common cancer in humans | 27.3 | 0 | 2 |
| Sun exposure, skin cancers and related skin conditions | 27.3 | 0 | 2 |
| Issues in the delivery of dermatologic surgery for skin cancer | 27.3 | 0 | 2 |
| Cutaneous Squamous Cell Carcinoma (SCC) and the DNA Damage Response: pATM Expression Patterns in Pre-Malignant and Malignant Keratinocyte Skin Lesions | 27.3 | 0 | 2 |
| Actinic keratosis is squamous cell carcinoma. | 27.3 | 0 | 2 |
| Systemic glucocorticoid use and early-onset basal cell carcinoma | 27.3 | 0 | 2 |
| A simple intervention to reinforce awareness of tanning bed use and skin cancer in non‐medical skin care professionals in Southern California | 27.3 | 0 | 2 |
| Citrus consumption and risk of basal cell carcinoma and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Knowledge, understanding, and use of preventive strategies against nonmelanoma skin cancer in healthy and immunosuppressed individuals undergoing Mohs surgery | 27.3 | 0 | 2 |
| Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer | 27.3 | 0 | 2 |
| Using a Hydroquinone/Tretinoin-based Skin Care System Before and After Electrodesiccation and Curettage of Superficial Truncal Basal Cell Carcinoma: A Multicenter, Randomized, Investigator-blind, Controlled Study of Short-term Healing | 27.3 | 0 | 2 |
| Basal Cell Carcinoma Arising within Seborrheic Keratosis. | 27.3 | 0 | 2 |
| Confocal microscopy-guided laser ablation for superficial and early nodular Basal cell carcinoma: a promising surgical alternative for superficial skin cancers | 27.3 | 0 | 2 |
| Evaluating patient-centered care: feasibility of electronic data collection in hospitalized older adults | 27.3 | 0 | 2 |
| Discrimination of basal cell carcinoma and melanoma from normal skin biopsies in vitro through Raman spectroscopy and principal component analysis | 27.3 | 0 | 2 |
| Sequential occurrence of basal cell carcinoma in symmetrically identical positions of both lower eyelids: A rare finding of a common skin cancer | 27.3 | 0 | 2 |
| Skin biopsies of pigmented skin lesions performed by general practitioners and hospital specialists. | 27.3 | 0 | 2 |
| Basal Cell Carcinoma and Seborrheic Keratosis: When Opposites Attract. | 27.3 | 0 | 2 |
| Initial presentation of acute myelogenous leukemia in the infiltrate underlying an actinic keratosis | 27.3 | 0 | 2 |
| Skin biopsy site selection in small animal dermatology with an introduction to histologic pattern-analysis of inflammatory skin lesions | 27.3 | 0 | 2 |
| Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer | 27.3 | 0 | 2 |
| From actinic keratosis to squamous cell carcinoma | 27.3 | 0 | 2 |
| HLA Antigen Profile Differences in Patients with SCC (Squamous Cell Carcinoma) In-Situ /Actinic Keratosis and Invasive SCC: Is There a Genetic Succeptibility for Invasive SCC Development? | 27.3 | 0 | 2 |
| Multiple sequential skin cancers. The risk of skin cancer in patients with previous skin cancer | 27.3 | 0 | 2 |
| Pagetoid variant of actinic keratosis with or without squamous cell carcinoma of sun-exposed skin: a lesion simulating extramammary Paget's disease | 27.3 | 0 | 2 |
| Genomic instability in human actinic keratosis and squamous cell carcinoma. | 27.3 | 0 | 2 |
| A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma | 27.3 | 0 | 2 |
| TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling | 27.3 | 0 | 2 |
| Efficacy of photodynamic therapy in the short and medium term in the treatment of actinic keratosis, Basal cell carcinoma, acne vulgaris and photoaging: results from four clinical trials | 27.3 | 0 | 2 |
| Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin). | 27.3 | 0 | 2 |
| Basal cell carcinoma-treatments for the commonest skin cancer | 27.3 | 0 | 2 |
| Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC | 27.3 | 0 | 2 |
| Surgical attitude in premalignant lesions and malignant tumors of the lower lip | 27.3 | 0 | 2 |
| Plantar basal cell carcinoma in a patient with xeroderma pigmentosum: importance of dermoscopy for early diagnosis of nonpigmented skin cancer | 27.3 | 0 | 2 |
| 1064 nm long‐pulsed Nd:YAG laser treatment of basal cell carcinoma | 27.3 | 0 | 2 |
| Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil | 27.3 | 0 | 2 |
| Fundamentals of skin cancer/melanoma screening campaigns | 27.3 | 0 | 2 |
| Topical calcitriol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models | 27.3 | 0 | 2 |
| Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited | 27.3 | 0 | 2 |
| Health economic evaluation of non-melanoma skin cancer and actinic keratosis | 27.3 | 0 | 2 |
| Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management | 27.3 | 0 | 2 |
| Development of the facial skin care index: a health-related outcomes index for skin cancer patients | 27.3 | 0 | 2 |
| Actinic keratosis: the key event in the evolution from photoaged skin to squamous cell carcinoma. Therapy based on pathogenetic and clinical aspects | 27.3 | 0 | 2 |
| Ambient temperature and risk of first primary basal cell carcinoma: a nationwide United States cohort study | 27.3 | 0 | 2 |
| Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity | 27.3 | 0 | 2 |
| Malignant skin lesions in Oshogbo, Nigeria | 27.3 | 0 | 2 |
| Novel Approaches to Imaging Basal Cell Carcinoma | 27.3 | 0 | 2 |
| The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes | 27.3 | 0 | 2 |
| Comparison of morphologic criteria for actinic keratosis and squamous cell carcinoma using in vivo multiphoton tomography | 27.3 | 0 | 2 |
| Incorporation of Electronic Brachytherapy for Skin Cancer into a Community Dermatology Practice | 27.3 | 0 | 2 |
| Differential diagnosis of squamous cell carcinoma in situ using skin histopathological images | 27.3 | 0 | 2 |
| Giant epithelial malignancies (Basal cell carcinoma, squamous cell carcinoma): a series of 20 tumors from a single center | 27.3 | 0 | 2 |
| Surgical margins of excision for basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Older Adults’ Mental Health Function and Patient-Centered Care: Does the Presence of a Family Companion Help or Hinder Communication? | 27.3 | 0 | 2 |
| Breast carcinoma masquerading as basal cell carcinoma of the nipple | 27.3 | 0 | 2 |
| Factors associated with false-negative endoscopic biopsy results after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma | 27.3 | 0 | 2 |
| Optimum treatment strategies for actinic keratosis (intraepidermal squamous cell carcinoma). | 27.3 | 0 | 2 |
| Two Cases of Cutaneous Squamous Cell Carcinoma Arising in Immunosuppressed Patients with Chronic Human Papillomavirus Infection | 27.3 | 0 | 2 |
| Expression of E-, P- and N-Cadherin and Its Clinical Significance in Cervical Squamous Cell Carcinoma and Precancerous Lesions | 27.3 | 0 | 2 |
| A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh | 27.3 | 0 | 2 |
| Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study | 27.3 | 0 | 2 |
| Squamous cell carcinoma and basal cell carcinoma arising in a naevus sebaceous of Jadassohn: case report and literature review | 27.3 | 0 | 2 |
| Improving the applicability of guidelines on nonmelanoma skin cancer in frail older adults: a multidisciplinary expert consensus and systematic review of current guidelines | 27.3 | 0 | 2 |
| Presurgical mapping of basal cell carcinoma or squamous cell carcinoma by confocal laser endomicroscopy compared to traditional micrographic surgery: a single-centre prospective feasibility study | 27.3 | 0 | 2 |
| New histopathological classification of actinic keratosis (incipient intraepidermal squamous cell carcinoma). | 27.3 | 0 | 2 |
| Analysis of debrided and non-debrided invasive squamous cell carcinoma skin lesions by in vivo reflectance confocal microscopy before and after therapy | 27.3 | 0 | 2 |
| The current role of in vivo reflectance confocal microscopy within the continuum of actinic keratosis and squamous cell carcinoma: a systematic review | 27.3 | 0 | 2 |
| The diagnostic concordance of actinic keratosis and squamous cell carcinoma | 27.3 | 0 | 2 |
| Expression of metallothioneins in cutaneous squamous cell carcinoma and actinic keratosis. | 27.3 | 0 | 2 |
| Female estrogen-related factors and incidence of basal cell carcinoma in a nationwide US cohort | 27.3 | 0 | 2 |
| Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey | 27.3 | 0 | 2 |
| The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro | 27.3 | 0 | 2 |
| Basal cell carcinoma mistaken for actinic keratosis | 27.3 | 0 | 2 |
| Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer | 27.3 | 0 | 2 |
| Protein kinase Cepsilon and development of squamous cell carcinoma, the nonmelanoma human skin cancer | 27.3 | 0 | 2 |
| Multifocal squamous cell carcinoma arising in a Favre-Racouchot lesion – report of two cases and review of the literature | 27.3 | 0 | 2 |
| Pattern of HPV infection in basal cell carcinoma and in perilesional skin biopsies from immunocompetent patients | 27.3 | 0 | 2 |
| Collision tumor of malignant skin cancers: a case of melanoma in basal cell carcinoma | 27.3 | 0 | 2 |
| Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis | 27.3 | 0 | 2 |
| Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness. | 27.3 | 0 | 2 |
| Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy | 27.3 | 0 | 2 |
| Topical therapy in the treatment of actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions | 27.3 | 0 | 2 |
| Tolerability of Ingenol Mebutate Gel, 0.05%, for Treating Patients with Actinic Keratosis on the Scalp in a Community Dermatology Practice | 27.3 | 0 | 2 |
| A Randomized, Double-blind, Placebo-controlled Clinical Trial Evaluating an Oral Anti-aging Skin Care Supplement for Treating Photodamaged Skin | 27.3 | 0 | 2 |
| Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Crossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacological issues | 27.3 | 0 | 2 |
| Human polyomaviruses and incidence of cutaneous squamous cell carcinoma in the New Hampshire skin cancer study | 27.3 | 0 | 2 |
| Distribution of Basal Cell Carcinoma and Squamous Cell Carcinoma by Facial Esthetic Unit | 27.3 | 0 | 2 |
| Reduced P53 staining in actinic keratosis is associated with squamous cell carcinoma: A preliminary study | 27.3 | 0 | 2 |
| Skin Cancer in the Crosshairs: Highlights from the Biennial Scientific Retreat of International Transplant Skin Cancer Collaborative and Skin Care in Organ Transplant Recipients Europe | 27.3 | 0 | 2 |
| Basal cell carcinoma of the skin with areas of squamous cell carcinoma: a basosquamous cell carcinoma? | 27.3 | 0 | 2 |
| Itch and Pain in Nonmelanoma Skin Cancer: Pain as an Important Feature of Cutaneous Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Non-O1 Vibrio cholerae inguinal skin and soft tissue infection with bullous skin lesions in a patient with a penis squamous cell carcinoma | 27.3 | 0 | 2 |
| Perineural invasion of cutaneous squamous cell carcinoma and basal cell carcinoma: raising awareness and optimizing management | 27.3 | 0 | 2 |
| Mycosis fungoides patient accompanied actinic keratosis, actinic keratosis with squamous cell carcinoma transformation, and porokeratosis after NBUVB therapy - 1st case report and review of the literature | 27.3 | 0 | 2 |
| Expression of heparanase in basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Patient Factors and Their Association with Nonmelanoma Skin Cancer Morbidity and the Performance of Self-skin Exams: A Cross-Sectional Study | 27.3 | 0 | 2 |
| Epstein-Barr virus and p16INK4A methylation in squamous cell carcinoma and precancerous lesions of the cervix uteri | 27.3 | 0 | 2 |
| Predicting risk of nonmelanoma skin cancer and premalignant skin lesions in renal transplant recipients | 27.3 | 0 | 2 |
| Physician Assistants And Nurse Practitioners Perform Effective Roles On Teams Caring For Medicare Patients With Diabetes | 27.3 | 0 | 2 |
| Aldehyde dehydrogenase 1 expression in basal cell carcinoma, actinic keratosis and Bowen’s disease | 27.3 | 0 | 2 |
| Pigmented Basal Cell Carcinoma in Marjolin’s Ulcer | 27.3 | 0 | 2 |
| Colonisation of Basal Cell Carcinoma and Actinic Keratosis by Malignant Melanoma In Situ in a Patient with Xeroderma Pigmentosum Variant | 27.3 | 0 | 2 |
| Does basal cell carcinoma belong to the spectrum of sorafenib-induced epithelial skin cancers? | 27.3 | 0 | 2 |
| Perineural infiltration of cutaneous squamous cell carcinoma and basal cell carcinoma without clinical features | 27.3 | 0 | 2 |
| Viral oncogenesis and its role in nonmelanoma skin cancer | 27.3 | 0 | 2 |
| Mohs surgery for squamous cell carcinoma. | 27.3 | 0 | 2 |
| Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications | 27.3 | 0 | 2 |
| FDG-PET/CT in radiation treatment planning of head and neck squamous cell carcinoma | 27.3 | 0 | 2 |
| A systematic review of advanced practice nurses’ skin cancer assessment barriers, skin lesion recognition skills, and skin cancer training activities | 27.3 | 0 | 2 |
| Malignant melanoma within squamous cell carcinoma and basal cell carcinoma: is it a combined or collision tumor?--a case report and review of the literature | 27.3 | 0 | 2 |
| Therapeutic Options to Decrease Actinic Keratosis and Squamous Cell Carcinoma Incidence and Progression in Solid Organ Transplant Recipients: A Practical Approach | 27.3 | 0 | 2 |
| AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for M | 27.3 | 0 | 2 |
| Dermatology of the head and neck: skin cancer and benign skin lesions | 27.3 | 0 | 2 |
| The influence of the location of the lesion on the absolute risk of the development of skin cancer in a patient with actinic keratosis | 27.3 | 0 | 2 |
| Effect of GSTM1 polymorphism on risks of basal cell carcinoma and squamous cell carcinoma: a meta-analysis | 27.3 | 0 | 2 |
| Resiquimod, a topical drug for viral skin lesions and skin cancer. | 27.3 | 0 | 2 |
| Common skin cancers in older adults: approach to diagnosis and management | 27.3 | 0 | 2 |
| Skin conditions: benign nodular skin lesions | 27.3 | 0 | 2 |
| Safety & efficacy of agents used for home mole removal and skin cancer treatment in the Internet age, and analysis of cases | 27.3 | 0 | 2 |
| Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control | 27.3 | 0 | 2 |
| Toward Patient-Centered Care: A Systematic Review of Older Adults’ Views of Quality Emergency Care | 27.3 | 0 | 2 |
| Skin biopsies in the assessment of the autonomic nervous system | 27.3 | 0 | 2 |
| Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system | 27.3 | 0 | 2 |
| Skin cancer and photoprotection in people of color: A review and recommendations for physicians and the public | 27.3 | 0 | 2 |
| Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice | 27.3 | 0 | 2 |
| Sinecatechins (Polyphenon E) ointment for treatment of external genital warts and possible future indications | 27.3 | 0 | 2 |
| New Therapeutic Options for Actinic Keratosis and Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Study to determine whether intraoperative frozen section biopsy improves surgical treatment of non-melanoma skin cancer | 27.3 | 0 | 2 |
| On the horizon: Optical imaging for cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Frequency of squamous cell carcinoma (SCC) invasion in transected SCC in situ referred for Mohs surgery: the Dartmouth−Hitchcock experience | 27.3 | 0 | 2 |
| Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung | 27.3 | 0 | 2 |
| Screening the pathogenic genes and pathways related to DMBA (7,12-dimethylbenz[a]anthracene)-induced transformation of hamster oral mucosa from precancerous lesions to squamous cell carcinoma | 27.3 | 0 | 2 |
| Association Between Mohs Surgery Wait Times and Surgical Defect Size in Patients With Squamous Cell or Basal Cell Carcinoma of the Skin | 27.3 | 0 | 2 |
| Topical therapies for skin cancer and actinic keratosis | 27.3 | 0 | 2 |
| Actinic keratosis and squamous cell carcinoma: clinical and pathological features | 27.3 | 0 | 2 |
| Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens | 27.3 | 0 | 2 |
| Mohs Surgery for Squamous Cell Carcinoma of the Nail Unit: 10 Years of Experience | 27.3 | 0 | 2 |
| Characteristics and outcomes of nonmelanoma skin cancer (NMSC) in children and young adults | 27.3 | 0 | 2 |
| Consensus for Nonmelanoma Skin Cancer Treatment, Part II: Squamous Cell Carcinoma, Including a Cost Analysis of Treatment Methods | 27.3 | 0 | 2 |
| The Patient-Centered Care and Receipt of Preventive Services Among Older Adults With Chronic Diseases: A Nationwide Cross-sectional Study | 27.3 | 0 | 2 |
| Photodynamic Therapy for Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review | 27.3 | 0 | 2 |
| Person‐Centered Care for Older Adults with Chronic Conditions and Functional Impairment: A Systematic Literature Review | 27.3 | 0 | 2 |
| Reconstruction of Large Facial Defects after Delayed Mohs Surgery for Skin Cancer | 27.3 | 0 | 2 |
| Actinic keratosis: preventable and treatable like other precancerous and cancerous skin lesions | 27.3 | 0 | 2 |
| Increased microRNA 21 expression contributes to arsenic induced skin lesions, skin cancers and respiratory distress in chronically exposed individuals | 27.3 | 0 | 2 |
| Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors | 27.3 | 0 | 2 |
| Atopic dermatitis in older adults: A viewpoint from geriatric dermatology | 27.3 | 0 | 2 |
| Liposomal systems as viable drug delivery technology for skin cancer sites with an outlook on lipid-based delivery vehicles and diagnostic imaging inputs for skin conditions'. | 27.3 | 0 | 2 |
| Diagnosis and Management of Hereditary Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| CONSENSUS REPORT: Recognizing non-melanoma skin cancer, including actinic keratosis, as an occupational disease - A Call to Action. | 27.3 | 0 | 2 |
| Questionnaire-based evaluation of occupational and non-occupational solar radiation exposure in a sample of Italian patients treated for actinic keratosis and other non-melanoma skin cancers. | 27.3 | 0 | 2 |
| CXCR7 expression correlates with tumor depth in cutaneous squamous cell carcinoma skin lesions and promotes tumor cell survival through ERK activation. | 27.3 | 0 | 2 |
| Self-reported quality of life after skin cancer in young adults | 27.3 | 0 | 2 |
| Food intake and risk of squamous cell carcinoma of the skin in a community: the Nambour skin cancer cohort study | 27.3 | 0 | 2 |
| Syntheses, biological evaluation and SAR of ingenol mebutate analogues for treatment of actinic keratosis and non-melanoma skin cancer | 27.3 | 0 | 2 |
| Automated Detection and Segmentation of Vascular Structures of Skin Lesions Seen in Dermoscopy, with an application to Basal Cell Carcinoma Classification | 27.3 | 0 | 2 |
| Second-intention healing of exposed facial-scalp bone after Mohs surgery for skin cancer: review of ninety-one cases. | 27.3 | 0 | 2 |
| Cutaneous melanin density of Caucasians measured by spectrophotometry and risk of malignant melanoma, basal cell carcinoma, and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Study of microvascular density and expression of vascular endothelial growth factor and its receptors in cancerous and precancerous lesions of the eyelids | 27.3 | 0 | 2 |
| Common Skin Conditions in Children: Neonatal Skin Lesions | 27.3 | 0 | 2 |
| Anatomical Distributions of Basal Cell Carcinoma and Squamous Cell Carcinoma in a Population-Based Study in Queensland, Australia. | 27.3 | 0 | 2 |
| From actinic keratosis to squamous cell carcinoma: pathophysiology revisited | 27.3 | 0 | 2 |
| Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients | 27.3 | 0 | 2 |
| Actinic damage and skin cancer in albinos in northern Tanzania: findings in 164 patients enrolled in an outreach skin care program | 27.3 | 0 | 2 |
| Survey of Patient Satisfaction With Ingenol Mebutate Gel Treatment for Actinic Keratosis From a Community Dermatology Practice | 27.3 | 0 | 2 |
| Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee | 27.3 | 0 | 2 |
| Incidence of skin cancers and precancerous lesions in Japanese--risk factors and prevention. | 27.3 | 0 | 2 |
| Early investigation by fluor-18-fluorodeoxyglucose positron emission tomography of a metastatic basal cell carcinoma presenting with spinal cord compression: A case report | 27.3 | 0 | 2 |
| Costs of Keratinocyte Carcinoma (Nonmelanoma Skin Cancer) and Actinic Keratosis Treatment in the Veterans Health Administration | 27.3 | 0 | 2 |
| Quantification of PpIX concentration in basal cell carcinoma and squamous cell carcinoma models using spatial frequency domain imaging | 27.3 | 0 | 2 |
| Dermatologic surgery practice and skin cancer treatment in Canada: results of a national survey | 27.3 | 0 | 2 |
| Basal cell carcinoma and squamous cell carcinoma. Recognition and treatment | 27.3 | 0 | 2 |
| Molecular discrimination of cutaneous squamous cell carcinoma from actinic keratosis and normal skin | 27.3 | 0 | 2 |
| Superficial basal cell carcinoma on the face is a diagnostic challenge | 27.3 | 0 | 2 |
| Validation of a diagnostic algorithm for the discrimination of actinic keratosis from normal skin and squamous cell carcinoma by means of high-definition optical coherence tomography | 27.3 | 0 | 2 |
| The use of high definition video modules for delivery of informed consent and wound care education in the Mohs Surgery Unit | 27.3 | 0 | 2 |
| Risks of different skin tumor combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population based cohorts: 1989 - 2009. | 27.3 | 0 | 2 |
| Mohs surgery for squamous cell carcinoma of the nail: report of 15 cases. Our experience and a long‐term follow‐up | 27.3 | 0 | 2 |
| Discrimination of squamous cell carcinoma in situ from seborrheic keratosis by color analysis techniques requires information from scale, scale-crust and surrounding areas in dermoscopy images | 27.3 | 0 | 2 |
| Racial differences in skin cancer awareness and surveillance practices at a public hospital dermatology clinic | 27.3 | 0 | 2 |
| Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer | 27.3 | 0 | 2 |
| Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma: A Population-Based Study in Olmsted County, Minnesota, 2000 to 2010. | 27.3 | 0 | 2 |
| Can video thermography improve differential diagnosis and therapy between basal cell carcinoma and actinic keratosis? | 27.3 | 0 | 2 |
| Skin cancers and precancerous lesions in Parkinson's disease patients. | 27.3 | 0 | 2 |
| A 13-Year Retrospective Study of Basal Cell Carcinoma in a Canadian Dermatology Practice: A Comparison Between Anatomical Location and Histopathologic Subtypes | 27.3 | 0 | 2 |
| Identifying and defining complications of dermatologic surgery to be tracked in the American College of Mohs Surgery (ACMS) Registry | 27.3 | 0 | 2 |
| Basal cell carcinoma in seborrheic keratosis | 27.3 | 0 | 2 |
| Pain evaluation in patients affected by cutaneous squamous cell carcinoma and actinic keratosis: an observational study | 27.3 | 0 | 2 |
| Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age. | 27.3 | 0 | 2 |
| Painful skin lesions and squamous cell carcinoma predict overall mortality risk in organ transplant recipients: a cohort study. | 27.3 | 0 | 2 |
| The Skin Cancer Objective Structured Clinical Examination (SCOSCE): A multi-institutional collaboration to develop and validate a clinical skills assessment for melanoma | 27.3 | 0 | 2 |
| MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions | 27.3 | 0 | 2 |
| Descriptive epidemiology of basal cell carcinoma and cutaneous squamous cell carcinoma in Soria (north-eastern Spain) 1998-2000: a hospital-based survey | 27.3 | 0 | 2 |
| Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior | 27.3 | 0 | 2 |
| Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study | 27.3 | 0 | 2 |
| Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma | 27.3 | 0 | 2 |
| Do Patients With End-Stage Chronic Renal Failure Treated With the Use of Hemodialysis Have Healthy Skin? Evaluation of Skin Lesions and Basic Education About Risk Factors for Skin Cancer in This Patient Population | 27.3 | 0 | 2 |
| Relationship between arsenic‐containing drinking water and skin cancers in the arseniasis endemic areas in Taiwan | 27.3 | 0 | 2 |
| Actinic keratosis and squamous cell carcinoma. | 27.3 | 0 | 2 |
| P16INK4aImmunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran | 27.3 | 0 | 2 |
| Results of second‐stage screening for skin cancers in Oita Prefecture, Japan | 27.3 | 0 | 2 |
| Surgical treatment of basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Treatment of basal cell carcinoma and squamous cell carcinoma with perineural invasion | 27.3 | 0 | 2 |
| Mohs surgery of basal cell carcinoma--a critical review | 27.3 | 0 | 2 |
| Subtype analysis and clinical significance of HPV infection in laryngeal squamous cell carcinoma and precancerous lesions | 27.3 | 0 | 2 |
| Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Risk of skin cancer in multiple myeloma patients: a retrospective cohort study | 27.3 | 0 | 2 |
| Primary cutaneous myxoid spindle cell squamous cell carcinoma: a rare skin cancer | 27.3 | 0 | 2 |
| Costs and Economics of Skin Cancer Management, Mohs Surgery, and Surgical Reconstruction | 27.3 | 0 | 2 |
| Profile of skin biopsies and patterns of skin cancer in a tertiary care center of Western Nepal | 27.3 | 0 | 2 |
| The development of non-melanocytic skin cancers in people with a history of skin cancer | 27.3 | 0 | 2 |
| Omental transplantation improves surgical outcome of large squamous cell carcinoma: A case report | 27.3 | 0 | 2 |
| Molecular epidemiology of skin cancers: DNA repair and non-melanocytic skin cancer | 27.3 | 0 | 2 |
| Excessive numbers of skin cancers and pre-malignant skin lesions in an Australian heart transplant recipient | 27.3 | 0 | 2 |
| Squamous cell carcinoma. Case report of an unusually aggressive skin cancer | 27.3 | 0 | 2 |
| Patterns of nodal metastases on 18F-FDG PET/CT in patients with esophageal squamous cell carcinoma are useful to guide treatment planning of radiotherapy. | 27.3 | 0 | 2 |
| Prognostic factors for cutaneous squamous cell and basal cell carcinoma. Determinants of risk of recurrence, metastasis, and development of subsequent skin cancers | 27.3 | 0 | 2 |
| Clinical characteristics of malignant tumours originating in the external ear | 27.3 | 0 | 2 |
| Genetic association between TNF-α promoter polymorphism and susceptibility to squamous cell carcinoma, basal cell carcinoma, and melanoma: A meta-analysis | 27.3 | 0 | 2 |
| Mouse models for actinic keratosis and squamous cell carcinoma | 27.3 | 0 | 2 |
| From sunlight to actinic keratosis to squamous cell carcinoma | 27.3 | 0 | 2 |
| Delivering value in dermatology: Insights from skin cancer detection in routine clinical visits | 27.3 | 0 | 2 |
| Childhood actinic keratosis in an albino transforming into squamous cell carcinoma. | 27.3 | 0 | 2 |
| Automatic detection of basal cell carcinoma using telangiectasia analysis in dermoscopy skin lesion images | 27.3 | 0 | 2 |
| Nodulocystic Basal Cell Carcinoma Arising Directly from a Seborrheic Keratosis: A Rare Case Report | 27.3 | 0 | 2 |
| Basal cell carcinoma arising within a seborrheic keratosis with respect to immunohistochemical characteristics | 27.3 | 0 | 2 |
| Use of Ber-EP4 and Epithelial Specific Antigen to Differentiate Clinical Simulators of Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Esophageal squamous cell carcinoma presenting with extensive skin lesions: a case report | 27.3 | 0 | 2 |
| Computer-Aided Decision Support for Melanoma Detection Applied on Melanocytic and Nonmelanocytic Skin Lesions: A Comparison of Two Systems Based on Automatic Analysis of Dermoscopic Images | 27.3 | 0 | 2 |
| Detection of Human Papillomavirus in Nonmelanoma Skin Cancer Lesions and Healthy Perilesional Skin in Kidney Transplant Recipients and Immunocompetent Patients | 27.3 | 0 | 2 |
| Patient-Centered Outcomes Research and Patient-Centered Care for Older Adults: A Perspective | 27.3 | 0 | 2 |
| Patient-centered professional practice models for managing low back pain in older adults: a pilot randomized controlled trial | 27.3 | 0 | 2 |
| Correction: E6 and E7 from Beta Hpv38 Cooperate with Ultraviolet Light in the Development of Actinic Keratosis-Like Lesions and Squamous Cell Carcinoma in Mice | 27.3 | 0 | 2 |
| Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Does the Dual Use of Toluidine Blue and Hematoxylin and Eosin Staining Improve Basal Cell Carcinoma Detection by Mohs Surgery Trainees? | 27.3 | 0 | 2 |
| Cytological diagnosis of basal cell carcinoma and actinic keratosis, using Papanicolaou and May-Grunwald-Giemsa stained cutaneous tissue smear | 27.3 | 0 | 2 |
| Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma | 27.3 | 0 | 2 |
| Clinicopathological analysis of basal cell carcinoma of the anal region and its distinction from basaloid squamous cell carcinoma | 27.3 | 0 | 2 |
| Excision vs Mohs surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| Basal cell carcinoma with tricholemmal (at the lower portion) differentiation within seborrheic keratosis | 27.3 | 0 | 2 |
| Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib | 27.3 | 0 | 2 |
| Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Two cases of basal cell carcinoma arising in seborrheic keratosis | 27.3 | 0 | 2 |
| Skin cancer: Basal cell carcinoma--pay your money, take your choice | 27.3 | 0 | 2 |
| Case of seborrheic keratosis with underlying basal cell carcinoma suggesting a collision tumor | 27.3 | 0 | 2 |
| Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer | 27.3 | 0 | 2 |
| Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Assessment of skin lesions and skin cancer using simple electrical impedance indices | 27.3 | 0 | 2 |
| Comparison of the microvasculature of basal cell carcinoma and actinic keratosis using intravital microscopy and immunohistochemistry | 27.3 | 0 | 2 |
| Basal cell carcinoma, oculo-cutaneous albinism and actinic keratosis in a native Indian. | 27.3 | 0 | 2 |
| Multiple Sequential Skin Cancers: The Risk of Skin Cancer in Patients With Previous Skin Cancer | 27.3 | 0 | 2 |
| Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure | 27.3 | 0 | 2 |
| BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia. | 27.3 | 0 | 2 |
| The expression of c-erbB-1 and c-erbB-2 oncogenes in basal cell carcinoma and squamous cell carcinoma of skin | 27.3 | 0 | 2 |
| Re: Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer | 27.3 | 0 | 2 |
| In vivo thickness measurement of basal cell carcinoma and actinic keratosis with optical coherence tomography and 20-MHz ultrasound | 27.3 | 0 | 2 |
| SEBORRHEIC KERATOSIS OR BASAL CELL CARCINOMA?A CASE REPORT | 27.3 | 0 | 2 |
| Ultrastructural localization of gap junction protein connexin 43 in normal human skin, basal cell carcinoma, and squamous cell carcinoma | 27.3 | 0 | 2 |
| Nonmelanoma Skin Cancer: Disease-Specific Quality-of-Life Concerns and Distress | 27.3 | 0 | 2 |
| Atypical Adnexal Tumors Adjacent to Basal Cell Carcinoma: A Difficult Problem in Patients with Brooke-Spiegler Syndrome Undergoing Mohs Surgery | 27.3 | 0 | 2 |
| Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients | 27.3 | 0 | 2 |
| Methyl aminolaevulinate-photodynamic therapy for actinic keratoses, squamous cell carcinoma in situ and superficial basal cell carcinoma employing a square wave intense pulsed light device for photoactivation | 27.3 | 0 | 2 |
| Prevalence of precancerous skin lesions and non-melanoma skin cancer in Japanese-Brazilians in Bauru, São Paulo State, Brazil | 27.3 | 0 | 2 |
| Marjolin's ulcer: immunohistochemical study of 17 cases and comparison with common squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| The basal lamina in basal cell carcinoma, bowen’s disease, squamous cell carcinoma and keratoacanthoma: an immunoperoxidase study using an antibody to type IV Collagen | 27.3 | 0 | 2 |
| P27 and mib1 expression in actinic keratosis, Bowen disease, and squamous cell carcinoma | 27.3 | 0 | 2 |
| Measurements of the anatomical distribution of erythemal ultraviolet: a study comparing exposure distribution to the site incidence of solar keratoses, basal cell carcinoma and squamous cell carcinoma. | 27.3 | 0 | 2 |
| The density of epidermal p53 clones is higher adjacent to squamous cell carcinoma in comparison with basal cell carcinoma. | 27.3 | 0 | 2 |
| Squamous cell carcinoma: Could it be the most common skin cancer? | 27.3 | 0 | 2 |
| Multidisciplinary management of advanced basal cell carcinoma: report of four cases | 27.3 | 0 | 2 |
| Occult basal cell carcinoma arising in seborrheic keratosis | 27.3 | 0 | 2 |
| A comparison of risk factors for malignant melanoma, squamous cell carcinoma and basal cell carcinoma in the UK. | 27.3 | 0 | 2 |
| Mohs surgery for basal cell carcinoma assisted by dermoscopy: report of two cases | 27.3 | 0 | 2 |
| See-and-treat surgery for facial skin cancer | 27.3 | 0 | 2 |
| Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area. | 27.3 | 0 | 2 |
| Altered distribution of 1-2B7B antigen in basal cell carcinoma, squamous cell carcinoma and Bowen's disease | 27.3 | 0 | 2 |
| Development of squamous cell carcinoma into basal cell carcinoma under treatment with Vismodegib | 27.3 | 0 | 2 |
| Treatment of aggressive basal cell carcinoma with intralesional interferon: Evaluation of efficacy by Mohs surgery | 27.3 | 0 | 2 |
| Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers | 27.3 | 0 | 2 |
| Nasal Valve Dysfunction after Mohs Surgery for Skin Cancer of the Nose | 27.3 | 0 | 2 |
| Basal Cell Carcinoma Treated with Mohs Surgery: A Comparison of 54 Younger Patients with 1050 Older Patients | 27.3 | 0 | 2 |
| Cowden's disease. Association with squamous cell carcinoma of the tongue and perianal basal cell carcinoma | 27.3 | 0 | 2 |
| Clinical triage of cutaneous squamous cell carcinoma and basal cell carcinoma to avoid treatment delay: value of an electronic booking system | 27.3 | 0 | 2 |
| On a Possible Protective Effect of HLA-A11 Against Skin Cancer and Keratotic Skin Lesions in Renal Transplant Recipients | 27.3 | 0 | 2 |
| Risk of subsequent non-melanoma skin cancer in a cohort of patients with primary basal cell carcinoma | 27.3 | 0 | 2 |
| High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia | 27.3 | 0 | 2 |
| Squamous cell carcinoma arising in seborrheic keratosis | 27.3 | 0 | 2 |
| Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin | 27.3 | 0 | 2 |
| Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians | 27.3 | 0 | 2 |
| Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. | 27.3 | 0 | 2 |
| Georgia's most common skin cancer: basal cell carcinoma | 27.3 | 0 | 2 |
| Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Unique basaloid findings during Mohs surgery for basal cell carcinoma: a dermatopathology challenge | 27.3 | 0 | 2 |
| Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Incidence and risk factors for skin cancer following lung transplantation | 27.3 | 0 | 2 |
| Multiple subclinical syringomatous proliferations encountered during Mohs surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| It's time for “keratinocyte carcinoma” to replace the term “nonmelanoma skin cancer” | 27.3 | 0 | 2 |
| Skin cancer evaluation in transplant patients: a physician opinion survey with recommendations | 27.3 | 0 | 2 |
| Squamous cell carcinoma of the maxillary sinus associated with nevoid basal cell carcinoma syndrome: report of a case with 21-year evaluation | 27.3 | 0 | 2 |
| Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma. | 27.3 | 0 | 2 |
| Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin | 27.3 | 0 | 2 |
| Vismodegib as a neoadjuvant treatment to Mohs surgery for aggressive basal cell carcinoma | 27.3 | 0 | 2 |
| Interferon therapy for basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Awareness, knowledge and attitudes to non-melanoma skin cancer and actinic keratosis among the general public | 27.3 | 0 | 2 |
| Family History of Skin Cancer Is Associated With Increased Risk of Cutaneous Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Preoperative Ultrasound and Photoacoustic Imaging of Nonmelanoma Skin Cancers | 27.3 | 0 | 2 |
| Lipid profile in actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Standard excision and reconstruction as an alternative to MMS for giant basal cell carcinoma? | 27.3 | 0 | 2 |
| A hyperkeratotic, clonal seborrheic keratosis accompanied by nodulocystic basal cell carcinoma. | 27.3 | 0 | 2 |
| A massive neglected giant basal cell carcinoma in a schizophrenic patient treated successfully with vismodegib | 27.3 | 0 | 2 |
| Patient Perception of Imiquimod Treatment for Actinic Keratosis and Superficial Basal Cell Carcinoma in 202 Patients. | 27.3 | 0 | 2 |
| Immunohistochemical assessment of endothelin-1 axis in psoriasis, basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Immunohistochemical study of the inflammatory infiltrate associated with feline cutaneous squamous cell carcinomas and precancerous lesions (actinic keratosis). | 27.3 | 0 | 2 |
| Topical Brimonidine Gel as a Hemostatic Agent After Dermatologic Surgery | 27.3 | 0 | 2 |
| BURNS and ERUPTS: novel mnemonics for detection of squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Basaloid squamous cell carcinoma with 'monster' cells: a mimic of pleomorphic basal cell carcinoma | 27.3 | 0 | 2 |
| Subsequent skin cancer in patients with early-onset basal cell carcinoma | 27.3 | 0 | 2 |
| Plasma antioxidant defense in actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Cutaneous Squamous Cell Carcinomas of the Lower Extremities Show Distinct Clinical and Pathologic Features | 27.3 | 0 | 2 |
| Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study | 27.3 | 0 | 2 |
| Key points in dermoscopic diagnosis of basal cell carcinoma and seborrheic keratosis in Japanese | 27.3 | 0 | 2 |
| Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. | 27.3 | 0 | 2 |
| Basal cell carcinoma showing surface hyperkeratosis clinically mimicking seborrheic keratosis | 27.3 | 0 | 2 |
| Risk of skin cancer development in 672 patients affected by actinic keratosis | 27.3 | 0 | 2 |
| Squamous cell carcinoma and basal cell carcinoma within the clinical picture of a chronic venous insufficiency in the third stage | 27.3 | 0 | 2 |
| Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years. | 27.3 | 0 | 2 |
| Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. | 27.3 | 0 | 2 |
| Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. | 27.3 | 0 | 2 |
| Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen | 27.3 | 0 | 2 |
| Giant basal cell carcinoma of the face: surgical management and challenges for reconstruction | 27.3 | 0 | 2 |
| Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase in squamous cell carcinoma and basal cell carcinoma of the skin | 27.3 | 0 | 2 |
| Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease | 27.3 | 0 | 2 |
| Reliability of Self-Reported Information on Skin Cancer Among Elderly Patients with Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Limitations of Ber‐EP4 for distinction of Bowen disease from basal cell carcinoma | 27.3 | 0 | 2 |
| Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma | 27.3 | 0 | 2 |
| Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate | 27.3 | 0 | 2 |
| 3D histology-guided surgery for basal cell carcinoma and squamous cell carcinoma: recurrence rates and clinical outcome | 27.3 | 0 | 2 |
| Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma | 27.3 | 0 | 2 |
| A Unique Basaloid Proliferation Encountered During Mohs Surgery: Potential Pitfall for Overdiagnosis of Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Multiple fibroepithelial basal cell carcinoma of Pinkus associated with seborrheic keratosis in a nevoid distribution | 27.3 | 0 | 2 |
| Immunohistochemical study on keratin expression in certain cutaneous epithelial neoplasms. Basal cell carcinoma, pilomatricoma, and seborrheic keratosis | 27.3 | 0 | 2 |
| Comparison of EMA,CEA, CD10 and Bcl-2 Biomarkers by Immunohistochemistry in Squamous Cell Carcinoma and Basal Cell Carcinoma of the Skin | 27.3 | 0 | 2 |
| Expression of Podoplanin in Non-melanoma Skin Cancers and Actinic Keratosis | 27.3 | 0 | 2 |
| Amyloid in basal cell carcinoma and seborrheic keratosis | 27.3 | 0 | 2 |
| Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma | 27.3 | 0 | 2 |
| Skin cancer. Melanoma and other specific nonmelanoma skin cancers | 27.3 | 0 | 2 |
| Expression of Minichromosome Maintenance Proteins in Actinic Keratosis and Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| A new algorithm for the discrimination of actinic keratosis from normal skin and squamous cell carcinoma based on in vivo analysis of optical properties by high-definition optical coherence tomography. | 27.3 | 0 | 2 |
| Basal cell carcinoma screening drives a comprehensive approach to skin cancer | 27.3 | 0 | 2 |
| Image analysis for quantification of nucleolar organizer regions in basal cell carcinoma and seborrheic keratosis | 27.3 | 0 | 2 |
| Mohs surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| A Limited Immunohistochemical Panel to Distinguish Basal Cell Carcinoma of Cutaneous Origin From Basaloid Squamous Cell Carcinoma of the Head and Neck | 27.3 | 0 | 2 |
| Effects of ultraviolet radiation exposure on FOXP3+ infiltration in cutaneous squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Diagnostic accuracy of optical coherence tomography in actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Nonpigmented skin lesions - how many are nonmelanoma skin cancer? | 27.3 | 0 | 2 |
| Follicular proliferation or basal cell carcinoma? The first prospective U.K. study of this histological challenge during Mohs surgery | 27.3 | 0 | 2 |
| p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis | 27.3 | 0 | 2 |
| Predicted cases of U.K. skin squamous cell carcinoma and basal cell carcinoma in 2020 and 2025: horizon planning for National Health Service dermatology and dermatopathology | 27.3 | 0 | 2 |
| The nevoid basal cell carcinoma syndrome--Gorlin's syndrome. Multiple jaw cysts and skin cancer | 27.3 | 0 | 2 |
| Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study | 27.3 | 0 | 2 |
| Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma-Reply | 27.3 | 0 | 2 |
| Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Epidemiology of basal cell carcinoma and squamous cell carcinoma of the pinna | 27.3 | 0 | 2 |
| Basal cell carcinoma growth in patients waiting for Mohs surgery: a prospective study | 27.3 | 0 | 2 |
| Standard step sectioning of skin biopsy specimens diagnosed as superficial basal cell carcinoma frequently yields deeper and more aggressive subtypes | 27.3 | 0 | 2 |
| Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients | 27.3 | 0 | 2 |
| Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma | 27.3 | 0 | 2 |
| Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinoma. | 27.3 | 0 | 2 |
| Prevalence of actinic skin lesions in patients with basal cell carcinoma of the head: a case-control study | 27.3 | 0 | 2 |
| Stereological study of desmosomes in basal cell carcinoma and seborrheic keratosis. | 27.3 | 0 | 2 |
| Skin cancer and surgical margins for basal cell carcinoma | 27.3 | 0 | 2 |
| The Method of En Face Frozen Section in Clearing Periocular Basal Cell Carcinoma and Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Photodynamic therapy effective for the treatment of actinic keratosis and basal cell carcinoma in bullous pemphigoid patients | 27.3 | 0 | 2 |
| Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Telomerase activity in Kaposi's sarcoma, squamous cell carcinoma, and basal cell carcinoma. | 27.3 | 0 | 2 |
| Polymorphisms in the DNA repair gene XRCC1 associated with basal cell carcinoma and squamous cell carcinoma of the skin in a Korean population | 27.3 | 0 | 2 |
| Sarcoidosis Discovered During Mohs Surgery for Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Altered p53 expression in benign and malignant skin lesions from renal transplant recipients and immunocompetent patients with skin cancer: correlation with human papillomaviruses? | 27.3 | 0 | 2 |
| Phasor-FLIM as a Screening Tool for the Differential Diagnosis of Actinic Keratosis, Bowen's Disease, and Basal Cell Carcinoma. | 27.3 | 0 | 2 |
| Dermoscopy, Confocal Microscopy and other Non-invasive Tools for the Diagnosis of Non-Melanoma Skin Cancers and Other Skin Conditions | 27.3 | 0 | 2 |
| Seborrheic Keratosis with Compound Nevus, Junctional Nevus and Basal Cell Carcinoma in the Same Lesion | 27.3 | 0 | 2 |
| Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib. | 27.3 | 0 | 2 |
| The Delphi panel in the economic evaluation of photodynamic therapy for actinic keratosis and basal cell carcinoma: poor results? | 27.3 | 0 | 2 |
| Nitric oxide and endothelin‐1,2 in actinic keratosis and basal cell carcinoma: changes in nitric oxide/endothelin ratio | 27.3 | 0 | 2 |
| Recurrent basal cell carcinoma and Mohs surgery. | 27.3 | 0 | 2 |
| Cyclin D and retinoblastoma gene product expression in actinic keratosis and cutaneous squamous cell carcinoma in relation to p53 expression | 27.3 | 0 | 2 |
| Hormonal and reproductive factors and incidence of basal cell carcinoma and squamous cell carcinoma in a large, prospective cohort. | 27.3 | 0 | 2 |
| Comparison of proteinase activities in squamous cell carcinoma, basal cell epithelioma, and seborrheic keratosis | 27.3 | 0 | 2 |
| Increased concentrations of 3,4-didehydroretinol and retinoic acid-binding protein (CRABPII) in human squamous cell carcinoma and keratoacanthoma but not in basal cell carcinoma of the skin | 27.3 | 0 | 2 |
| Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma | 27.3 | 0 | 2 |
| Correlation Between Incisional Biopsy Histological Subtype and a Mohs Surgery Specimen for Nonmelanoma Skin Cancer | 27.3 | 0 | 2 |
| Cutaneous Basal Cell Carcinoma with Dual Differentiation into Squamous Cell Carcinoma and Spindle Cell Squamous Cell Carcinoma: A Case Report with Immunohistochemical Studies | 27.3 | 0 | 2 |
| Microinvasive squamous cell carcinoma arising within seborrheic keratosis | 27.3 | 0 | 2 |
| The Ratio of Basal Cell Carcinoma to Squamous Cell Carcinoma in Houston, Texas | 27.3 | 0 | 2 |
| Cytological diagnosis of basal cell carcinoma and actinic keratosis, using Papanicolaou and May-Grünwald-Giemsa stained cutaneous tissue smear | 27.3 | 0 | 2 |
| Vitamin D Level and Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Risk | 27.3 | 0 | 2 |
| The effect of solar UVB doses and vitamin D production, skin cancer action spectra, and smoking in explaining links between skin cancers and solid tumours | 27.3 | 0 | 2 |
| Solitary sebaceous nevus of Jadassohn complicated by squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Topical tretinoin in actinic keratosis and basal cell carcinoma. | 27.3 | 0 | 2 |
| Longitudinal diminution of tumor size for basal cell carcinoma suggests shifting referral patterns for Mohs surgery | 27.3 | 0 | 2 |
| Frequency of skin cancer and other ultraviolet radiation provoked skin lesions of eyelid and periocular region in the 1981-1992 period | 27.3 | 0 | 2 |
| Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients | 27.3 | 0 | 2 |
| A pilot study comparing toluidine blue and hematoxylin and eosin staining of basal cell and squamous cell carcinoma during Mohs surgery | 27.3 | 0 | 2 |
| Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Seroreactivity to cutaneous human papillomaviruses among patients with nonmelanoma skin cancer or benign skin lesions | 27.3 | 0 | 2 |
| Correlation of histological subtypes of basal cell carcinoma with age, sex and distribution of skin lesions: a five-year study at Ramathibodi Hospital | 27.3 | 0 | 2 |
| Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update | 27.3 | 0 | 2 |
| Mohs surgery in the treatment of skin cancer. | 27.3 | 0 | 2 |
| Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin | 27.3 | 0 | 2 |
| Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group | 27.3 | 0 | 2 |
| Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck | 27.3 | 0 | 2 |
| Ingenol mebutate: A novel topical drug for actinic keratosis | 27.3 | 0 | 2 |
| Validity of skin cancer malignancy reporting to the Organ Procurement Transplant Network: A cohort study | 27.3 | 0 | 2 |
| Fluorescence diagnosis in actinic keratosis and squamous cell carcinoma | 27.3 | 0 | 2 |
| Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning | 27.3 | 0 | 2 |
| The value of mohs surgery for the treatment of nonmelanoma skin cancers | 27.3 | 0 | 2 |
| Expressions of receptor-interacting protein and caspase-8 in oral squamous cell carcinoma and oral precancerous lesions | 27.3 | 0 | 2 |
| Synthesis, biological evaluation and SAR of 3-benzoates of ingenol for treatment of actinic keratosis and non-melanoma skin cancer | 27.3 | 0 | 2 |
| International Survey Of Older Adults Finds Shortcomings In Access, Coordination, And Patient-Centered Care | 27.3 | 0 | 2 |
| Factors favoring skin cancer and precancerous skin conditions | 27.3 | 0 | 2 |
| Reflectance confocal microscopy: non-invasive distinction between actinic keratosis and squamous cell carcinoma. | 27.3 | 0 | 2 |
| Skin cancer knowledge and preventive behaviors among patients with a recent history of cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Older Adults’ Perspectives on Naturopathic Medicine’s Impact on Healthy Aging | 27.3 | 0 | 2 |
| Basal cell carcinoma arising in a seborrheic keratosis: a case report | 27.3 | 0 | 2 |
| Actinic keratosis: epidemiology and progression to squamous cell carcinoma | 27.3 | 0 | 2 |
| Office based dermatological surgery and Mohs surgery: A prospective audit of surgical procedures and complications in a procedural dermatology practice | 27.3 | 0 | 2 |
| Evaluation of selenium in biological sample of arsenic exposed female skin lesions and skin cancer patients with related to non-exposed skin cancer patients. | 27.3 | 0 | 2 |
| Squamous cell carcinoma of the eyelids. Review of 7 years of experience of the adult ophthalmology service of the Casablanca university medical center | 27.3 | 0 | 2 |
| Patient‐Centered Care for Older Adults with Multiple Chronic Conditions: These are the Polypathological Patients! | 27.3 | 0 | 2 |
| Mortality after dermatologic surgery for nonmelanoma skin cancer in patients aged 80 years and older | 27.3 | 0 | 2 |
| Aging skin is functionally anaerobic: importance of coenzyme Q10 for anti aging skin care | 27.3 | 0 | 2 |
| Detection of human papillomavirus in cutaneous clear cell squamous cell carcinoma in situ: viral-associated oncogenesis may contribute to the development of this pathologic variant of skin cancer | 27.3 | 0 | 2 |
| Expression of promyelocytic leukaemia protein in Bowen's disease, skin squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| In actinic keratosis and basal cell carcinoma. The power of light heals without scars | 27.3 | 0 | 2 |
| Characteristics of office-based visits for skin cancer. Dermatologists have more experience than other physicians in managing malignant and premalignant skin conditions | 27.3 | 0 | 2 |
| US patients get faster access to botulinum toxin than for suspicious mole checks | 27.3 | 0 | 2 |
| Role of Children in End-of-Life Treatment Planning Among Korean American Older Adults | 27.3 | 0 | 2 |
| Acantholytic squamous cell carcinoma is usually associated with hair follicles, not acantholytic actinic keratosis, and is not "high risk": Diagnosis, management, and clinical outcomes in a series of 115 cases | 27.3 | 0 | 2 |
| Increased osteopontin expression is associated with progression from vulvar precancerous lesions to vulvar squamous cell carcinoma | 27.3 | 0 | 2 |
| Skin conditions in community-living older adults: prevalence and characteristics of medical care service use. | 27.3 | 0 | 2 |
| Age transcended: a semiotic and rhetorical analysis of the discourse of agelessness in North American anti-aging skin care advertisements | 27.3 | 0 | 2 |
| The Skin Cancer Quality of Life Impact Tool (SCQOLIT): a validated health-related quality of life questionnaire for non-metastatic skin cancers | 27.3 | 0 | 2 |
| Portable video media for presenting informed consent and wound care instructions for skin biopsies: a randomized controlled trial | 27.3 | 0 | 2 |
| UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer | 27.3 | 0 | 2 |
| Differences in Nursing Home Quality Between Medicare Advantage and Traditional Medicare Patients | 27.3 | 0 | 2 |
| Topical chemotherapy for actinic keratosis and nonmelanoma skin cancer: current options and future perspectives | 27.3 | 0 | 2 |
| Donor-derived keratinocytes in actinic keratosis and squamous cell carcinoma in patients with kidney transplant | 27.3 | 0 | 2 |
| Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics. | 27.3 | 0 | 2 |
| Factors Influencing Squamous Cell Carcinoma In Situ Recurrence and Implications for Treatment Choice | 27.3 | 0 | 2 |
| How Mohs Surgery Transformed Into a First-Line Treatment of Skin Cancer | 27.3 | 0 | 2 |
| Frequency of seborrheic keratosis biopsies in the United States: a benchmark of skin lesion care quality and cost effectiveness | 27.3 | 0 | 2 |
| Curricular factors associated with medical students' practice of the skin cancer examination: an educational enhancement initiative by the integrated skin exam consortium | 27.3 | 0 | 2 |
| Histomorphology and Immunophenotype of Eczematous Skin Lesions Revisited-Skin Biopsies Are Not Reliable in Differentiating Allergic Contact Dermatitis, Irritant Contact Dermatitis, and Atopic Dermatitis | 27.3 | 0 | 2 |
| Celebrating 30 Years of the Clinical Symposium on Advances in Skin & Wound Care | 27.3 | 0 | 2 |
| An ecological study of skin biopsies and skin cancer treatment procedures in the United States Medicare population, 2000 to 2015. | 27.3 | 0 | 2 |
| Costs and Trends in Utilization of Low-value Services Among Older Adults With Commercial Insurance or Medicare Advantage | 27.3 | 0 | 2 |
| Clinical usefulness of Mohs' chemosurgery for palliative purposes in patients with cutaneous squamous cell carcinoma with risk factors or without indication for surgery: Three case reports | 27.3 | 0 | 2 |
| Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancer. | 27.3 | 0 | 2 |
| High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma. | 27.3 | 0 | 2 |
| Association between Skin Conditions and Depressive Disorders in Community-Dwelling Older Adults | 27.3 | 0 | 2 |
| What's up dermatology? A pilot survey of the use of WhatsApp in dermatology practice and case discussion among members of WhatsApp dermatology groups. | 27.3 | 0 | 2 |
| Mole Mapping for Management of Pigmented Skin Lesions | 27.3 | 0 | 2 |
| Skin care and the topical treatment of aging skin | 27.3 | 0 | 2 |
| Recommendations for Solid Organ Transplantation for Transplant Candidates With a Pretransplant Diagnosis of Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma and Melanoma: A Consensus Opinion From the International Transplant Skin Cancer Coll | 27.3 | 0 | 2 |
| Patient-centered care in wound care | 27.3 | 0 | 2 |
| Features Causing Confusion between Basal Cell Carcinoma and Squamous Cell Carcinoma in Clinical Diagnosis | 27.3 | 0 | 2 |
| Incidence of Actinic Keratosis and Risk of Skin Cancer in Subjects with Actinic Keratosis: A Population-based Cohort Study | 27.3 | 0 | 2 |
| Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression | 27.3 | 0 | 2 |
| Skin Lesion Analysis towards Melanoma Detection Using Deep Learning Network | 27.3 | 0 | 2 |
| Actinic keratosis area and severity index (AKASI) is associated with the incidence of squamous cell carcinoma | 27.3 | 0 | 2 |
| Re: "How Mohs Surgery Transformed Into a First-Line Treatment of Skin Cancer". | 27.3 | 0 | 2 |
| Evaluation of T lymphocyte subpopulations in Actinic Keratosis, In Situ and Invasive Squamous Cell Carcinoma of the Skin. | 27.3 | 0 | 2 |
| Actinic keratosis-related signs predictive of squamous cell carcinoma in renal transplant recipients: a nested case-control study | 27.3 | 0 | 2 |
| Family history of skin cancer is associated with early-onset basal cell carcinoma independent of MC1R genotype. | 27.3 | 0 | 2 |
| Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model | 27.3 | 0 | 2 |
| ASSESSMENT OF THE KNOWLEDGE AND ATTITUDES OF NURSES ON THE SKIN CONDITION AND TREATMENT OF DAMAGE | 27.3 | 0 | 2 |
| Pigmented lesion on the temple. Pigment cell tumor, basal cell carcinoma, or irritated seborrheic keratosis? | 27.3 | 0 | 2 |
| Actinic keratosis: a cross‐sectional study of disease characteristics and treatment patterns in Danish dermatology clinics | 27.3 | 0 | 2 |
| Skin lesion image segmentation using Delaunay Triangulation for melanoma detection | 27.3 | 0 | 2 |
| Expressions of oncogenes c-fos and c-myc in skin lesion of cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Burden of Malignancy After a Primary Skin Cancer: Recurrence, Multiple Skin Cancers and Second Primary Cancers | 27.3 | 0 | 2 |
| False-negative findings in skin cancer and melanoma screening. | 27.3 | 0 | 2 |
| Lack of selective attendance of participants at skin cancer/melanoma screening clinics | 27.3 | 0 | 2 |
| General practitioners' workload after skin cancer/melanoma screening clinics in The Netherlands | 27.3 | 0 | 2 |
| Melanonychia following mohs surgery for recurrent squamous cell carcinoma in situ of the nail bed. | 27.3 | 0 | 2 |
| Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma | 27.3 | 0 | 2 |
| Physician Survey Regarding Patient Nonattendance at Follow-up Appointments at a University-Affiliated Medical Dermatology Clinic | 27.3 | 0 | 2 |
| The ratio of non-hyperkeratotic and hyperkeratotic actinic keratosis in a high-risk non-melanoma skin cancer cohort in Queensland | 27.3 | 0 | 2 |
| The Accuracy of Measurements of Nonmelanoma Skin Cancer Sizes Referred to the Mohs Surgery Clinic | 27.3 | 0 | 2 |
| The frequency and nature of skin conditions seen in a private dermatology practice in central Victoria, 1991-95. | 27.3 | 0 | 2 |
| W-modification of Abbe flap after Mohs surgery of squamous cell carcinoma on the lower lip. | 27.3 | 0 | 2 |
| Three years of retrospective evaluation of skin biopsy results in childhood | 27.3 | 0 | 2 |
| A retrospective study of endoscopic resection for 368 patients with early esophageal squamous cell carcinoma or precancerous lesions | 27.3 | 0 | 2 |
| Actinic keratosis. A premalignant skin lesion | 27.3 | 0 | 2 |
| A report from the 22nd Congress of the European Academy of Dermatology and Venereology (October 2-6, 2013, Istanbul, Turkey) | 27.3 | 0 | 2 |
| Computer aided analysis of epi-illumination and transillumination images of skin lesions for diagnosis of skin cancers | 27.3 | 0 | 2 |
| Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Arsenic-induced skin conditions identified in southwest dermatology practices: an epidemiologic tool? | 27.3 | 0 | 2 |
| How good are skin cancer clinics at melanoma detection? Number needed to treat variability across a national clinic group in Australia | 27.3 | 0 | 2 |
| Expression and clinical implications of enhancer of Zeste homolog 2 and p53 protein in squamous cell carcinoma and precancerous lesions in the cervix | 27.3 | 0 | 2 |
| Multi-Center, Double-Blind, Vehicle-Controlled Clinical Trial of an Alpha and Beta Defensin-Containing Anti-Aging Skin Care Regimen With Clinical, Histopathologic, Immunohistochemical, Photographic, and Ultrasound Evaluation | 27.3 | 0 | 2 |
| Progression of skin lesions from normal skin to squamous cell carcinoma. | 27.3 | 0 | 2 |
| Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression | 27.3 | 0 | 2 |
| Treatment Planning Considerations in Older Adults | 27.3 | 0 | 2 |
| Aggressive Squamous Cell Carcinoma Within A Burn Scar Complicated by M. Fortuitum Infection: Combination Treatment With Antibiotic Therapy, Mohs Surgery, Amnion-Chorion Graft, and Low-Intensity Pulsed Dye Laser | 27.3 | 0 | 2 |
| Expression of Mcm7 and Cdc6 in oral squamous cell carcinoma and precancerous lesions. | 27.3 | 0 | 2 |
| Immunohistochemical study of the specific features of expression of matrix metalloproteinases 1, 9 in the photoaged skin, the foci of actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Cytological screening and 15 years' follow-up (1986-2001) for early esophageal squamous cell carcinoma and precancerous lesions in a high-risk population in Anyang County, Henan Province, Northern China | 27.3 | 0 | 2 |
| Basic skin cancer triage for teaching melanoma detection | 27.3 | 0 | 2 |
| Alterations of the Human Skin N- and O-Glycome in Basal Cell Carcinoma and Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS. | 27.3 | 0 | 2 |
| Therapeutic potential of the anti‐diabetic agent metformin in targeting the skin cancer stem cell diaspora | 27.3 | 0 | 2 |
| Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis | 27.3 | 0 | 2 |
| The depth of follicular extension in actinic keratosis correlates with the depth of invasion in squamous cell carcinoma: implication for clinical treatment | 27.3 | 0 | 2 |
| Neoplastic Multifocal Skin Lesions: Biology, Etiology, and Targeted Therapies for Nonmelanoma Skin Cancers. | 27.3 | 0 | 2 |
| In vivo microvascular imaging of cutaneous actinic keratosis, Bowen's disease and squamous cell carcinoma using dynamic optical coherence tomography. | 27.3 | 0 | 2 |
| Diospyros lotus leaf and grapefruit stem extract synergistically ameliorate atopic dermatitis-like skin lesion in mice by suppressing infiltration of mast cells in skin lesions | 27.3 | 0 | 2 |
| Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification | 27.3 | 0 | 2 |
| Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Methyl-aminolevulinic acid photodynamic therapy for actinic keratoses: a useful treatment or a risk factor? A retrospective study | 27.3 | 0 | 2 |
| Expression of p300 and p300/CBP associated factor (PCAF) in actinic keratosis and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Invasive Squamous Cell Carcinoma With Clear Cell Change of the Eyelid Arising in a Seborrheic Keratosis | 27.3 | 0 | 2 |
| The serine protease inhibitor of Kazal-type 9 (SPINK9) is expressed in lichen simplex chronicus, actinic keratosis and squamous cell carcinoma. | 27.3 | 0 | 2 |
| Strategies for patients with newly diagnosed oral squamous cell carcinoma and a positive chest CT. A cohort study on the effects on treatment planning and incidence | 27.3 | 0 | 2 |
| Use of 2-Octyl Cyanoacrylate to Obviate Daily Wound Care After Mohs Surgery | 27.3 | 0 | 2 |
| Expression of G1/S‐cyclins and cyclin‐dependent kinase inhibitors in actinic keratosis and squamous cell carcinoma | 27.3 | 0 | 2 |
| The expressions of cyclooxygenase-2 (Cox-2),VEGF in oral squamous cell carcinoma and precancerous lesions and their significances | 27.3 | 0 | 2 |
| The alteration of MTS1 gene in precancerous lesions and squamous cell carcinoma of oral mucosa | 27.3 | 0 | 2 |
| BRAF and RKIP aberrations in actinic keratosis and non-melanoma skin cancers | 27.3 | 0 | 2 |
| Squamous cell carcinoma arising within seborrheic keratosis | 27.3 | 0 | 2 |
| Don't blow your top: protecting the information trail in epidermis--fragile skin biopsies | 27.3 | 0 | 2 |
| Papillated squamous cell carcinoma in situ arising in a seborrheic keratosis | 27.3 | 0 | 2 |
| Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Investigation of Werner protein as an early DNA damage response in actinic keratosis, Bowen disease and squamous cell carcinoma | 27.3 | 0 | 2 |
| From actinic keratosis to squamous cell carcinoma: evidence of morphologic and biologic progression | 27.3 | 0 | 2 |
| Effectively Disclosing Skin Biopsy Results | 27.3 | 0 | 2 |
| [Mohs surgery for basal cell carcinoma]. | 27.3 | 0 | 2 |
| Lip Repair after Mohs Surgery for Squamous Cell Carcinoma by Bilateral Tissue Expanding Vermillion Myocutaneous Flap (Goldstein Technique Modified by Sawada). | 27.3 | 0 | 2 |
| Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma | 27.3 | 0 | 2 |
| Squamous Cell Carcinoma and Basal Cell Carcinoma--The Frontline for Pathophysiology. Diagnosis and Therapy | 27.3 | 0 | 2 |
| Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease | 27.3 | 0 | 2 |
| A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosis | 27.3 | 0 | 2 |
| Comparison of P53 Intensity, Frequency and Size in Normal Skin Periphery of Squamous Cell Carcinoma, Basal Cell Carcinoma And Melanocytic Nevus in Persian Skin Type | 27.3 | 0 | 2 |
| Dysregulation of epidermal growth factor receptor in actinic keratosis and squamous cell carcinoma | 27.3 | 0 | 2 |
| Differentiation of seborrheic keratosis from basal cell carcinoma, nevi and melanoma by RGB autofluorescence imaging | 27.3 | 0 | 2 |
| Management of Patients With Skin Cancers: Basal Cell Carcinoma and Melanoma. | 27.3 | 0 | 2 |
| Efficacy and safety of endoscopic submucosal tunnel dissection for superficial esophageal squamous cell carcinoma and precancerous lesions | 27.3 | 0 | 2 |
| Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme | 27.3 | 0 | 2 |
| Who attends skin cancer clinics within a randomized melanoma screening program? | 27.3 | 0 | 2 |
| Attitudes and intentions in relation to skin checks for early signs of skin cancer | 27.3 | 0 | 2 |
| A Predictive Model for Primary Closure Lengths in Mohs Surgery Based on Skin Cancer Type, Dimensions, and Location | 27.3 | 0 | 2 |
| A guide to treatment planning in complex older adults | 27.3 | 0 | 2 |
| Case Report: Squamous Cell Carcinoma Referred for Mohs Surgery Found to be Cutaneous Leishmaniasis | 27.3 | 0 | 2 |
| Enhanced expression of nidogen 1 around the nest of basal cell carcinoma compared with that around squamous cell carcinoma | 27.3 | 0 | 2 |
| Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma | 27.3 | 0 | 2 |
| A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes | 27.3 | 0 | 2 |
| Faculty of 1000 evaluation for Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling | 27.3 | 0 | 2 |
| Immunological effects of photodynamic therapy in the treatment of actinic keratosis and squamous cell carcinoma | 27.3 | 0 | 2 |
| Faculty of 1000 evaluation for Actinic keratosis-related signs predictive of squamous cell carcinoma in renal transplant recipients: a nested case-control study | 27.3 | 0 | 2 |
| 1562. Impact of Skin Biopsy on Diagnosing Infections and Changing Treatment in Cancer Patients with New Skin Rash | 27.3 | 0 | 2 |
| Expression of Gelatinases (MMP-2, MMP-9) and Gelatinase Activator (MMP-14) in Actinic Keratosis and in In Situ and Invasive Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Keratinocyte carcinomas arising near arteriovenous fistulas: Case series and safety considerations for dermatologic surgery: A report of the International Transplant Skin Cancer Collaborative | 27.3 | 0 | 2 |
| Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adults | 27.3 | 0 | 2 |
| Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults | 27.3 | 0 | 2 |
| Checking Wether the m-ALA Cream Could Mark Correctly the Borders of BCC's Tumors | 27.3 | 0 | 2 |
| Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors | 27.3 | 0 | 2 |
| Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project | 27.3 | 0 | 2 |
| Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer | 27.3 | 0 | 2 |
| Mobile Teledermatology for Melanoma Detection. Assessment of Validity in the Framework of a Population-based Skin Cancer Awareness Campaign in Northern Italy | 27.3 | 0 | 2 |
| Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-Scope | 27.3 | 0 | 2 |
| SNaP Wound Care System Over Skin Cancer Excision Sites and Split Thickness Skin Grafts (STSGs) | 27.3 | 0 | 2 |
| Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer | 27.3 | 0 | 2 |
| Pilot Study of PDL to Treat BCC and SCCIS | 27.3 | 0 | 2 |
| Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC) | 27.3 | 0 | 2 |
| Skin cancer precursor immunotherapy for squamous cell carcinoma prevention | 27.3 | 0 | 2 |
| Seborrheic keratosis evolution into squamous cell carcinoma: A truly modified sun-related tumor? A case report and review of the literature | 27.3 | 0 | 2 |
| A Distinct Epidemiological Pattern of Precancerous Lesions of Esophageal Squamous Cell Carcinoma in a High-Risk Area of Huai'an,Jiangsu Province,China | 27.3 | 0 | 2 |
| Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers | 27.3 | 0 | 2 |
| Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis | 27.3 | 0 | 2 |
| Occult Basal Cell Carcinoma Arising in Seborrheic Keratosis | 27.3 | 0 | 2 |
| T-Cadherin Expression in Actinic Keratosis Transforming to Invasive Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC | 27.3 | 0 | 2 |
| Topical Green Tea Ointment in Treatment of Superficial Skin Cancer | 27.3 | 0 | 2 |
| Actinic Keratosis Study | 27.3 | 0 | 2 |
| Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection. | 27.3 | 0 | 2 |
| Precancerous Lesions of Squamous Cell Carcinoma of the Cervix: Squamous Dysplasia | 27.3 | 0 | 2 |
| Nanocytology Test to Evaluate Skin Cancer in High Risk Patients | 27.3 | 0 | 2 |
| A Comparison Study of the Tensile Strength of Sutures Used in Dermatologic Surgery on the Day of Suture Removal, Following Wound Care With Two Different Products | 27.3 | 0 | 2 |
| Basal Cell Carcinoma Recurrence After Mohs Surgery | 27.3 | 0 | 2 |
| Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer | 27.3 | 0 | 2 |
| Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer | 27.3 | 0 | 2 |
| Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma. | 27.3 | 0 | 2 |
| Nodal staging of high-risk cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics | 27.3 | 0 | 2 |
| Website Application Based Education and Text Messaging in Improving Skin Wound Care in Patients Undergoing Mohs Surgery | 27.3 | 0 | 2 |
| Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia | 27.3 | 0 | 2 |
| Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| Bioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions | 27.3 | 0 | 2 |
| Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear | 27.3 | 0 | 2 |
| Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer | 27.3 | 0 | 2 |
| Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| Isotretinoin in Preventing Skin Cancer | 27.3 | 0 | 2 |
| Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis | 27.3 | 0 | 2 |
| Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp | 27.3 | 0 | 2 |
| DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients | 27.3 | 0 | 2 |
| Electronic Brachytherapy (eBx)-Mohs Matched Pair - Cohort Study A Multi-Center Retrospective-Prospective Matched Pairs Cohort Study to Assess Long-term Clinical Outcomes of Non-melanoma Skin Cancer Patients Treated With eBx Compared to Non-melan | 27.3 | 0 | 2 |
| Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer | 27.3 | 0 | 2 |
| Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer | 27.3 | 0 | 2 |
| Optical Spectroscopy for Skin Carcinomas' Surgical Management | 27.3 | 0 | 2 |
| Smartphone Application to Detect Skin Lesions | 27.3 | 0 | 2 |
| Reflectance Confocal Microscopy in Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Recognition of skin cancers: skin cancer awareness programs in Ohio | 27.3 | 0 | 2 |
| Basal cell carcinoma among the cases of Dermatology Clinic I of the Silesian Medical Academy in Katowice | 27.3 | 0 | 2 |
| New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up | 27.3 | 0 | 2 |
| Relationship between tumor cell invasion, metastasis and proteinases activities in squamous cell carcinoma, basal cell epithelioma and seborrheic keratosis | 27.3 | 0 | 2 |
| Statistical study of metastatic skin cancer--interrelation of the origin of primary tumor, metastatic skin lesions, prognosis and histopathology | 27.3 | 0 | 2 |
| Teaching comprehensive treatment planning within a patient-centered care model | 27.3 | 0 | 2 |
| Morphological studies on basal cell carcinoma and squamous cell carcinoma in vitro (author's transl) | 27.3 | 0 | 2 |
| Skin care for older adults. Nursing diagnosis: potential for impairment in skin integrity | 27.3 | 0 | 2 |
| Squamous cell carcinoma in situ (Bowen's disease) arising in seborrheic keratosis: three lesions in two patients | 27.3 | 0 | 2 |
| Subungual squamous cell carcinoma treated by Mohs surgery in a patient with sarcoidosis | 27.3 | 0 | 2 |
| Skin care for older adults. Wound cleansing | 27.3 | 0 | 2 |
| Skin care for older adults | 27.3 | 0 | 2 |
| Human papillomavirus (HPV) DNA sequences in oral precancerous lesions and squamous cell carcinoma demonstrated by in situ hybridization | 27.3 | 0 | 2 |
| Distribution of fibronectin and laminin in basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| [The dermatophytic flora surveyed at the Dermatology Clinic of the Tottori University Hospital from 1981 to 1984--statistic analysis of the patients of various clinical types and a comparative study of the ratios of T. rubrum/T. mentagrophytes at de | 27.3 | 0 | 2 |
| Epithelial skin cancers and precancerous lesions. Epidemiology, etiology (occupational etiologies inclusive), pathologic anatomy, diagnosis, prognosis, principles of the treatment | 27.3 | 0 | 2 |
| General principles for treatment planning for squamous cell carcinoma of the head and neck | 27.3 | 0 | 2 |
| Dermatologic surgery in aging skin | 27.3 | 0 | 2 |
| Porokeratosis large skin lesions are susceptible to skin cancer development: histological and cytological explanation for the susceptibility | 27.3 | 0 | 2 |
| Clinical misdiagnosis of squamous cell carcinoma in situ as seborrheic keratosis. A prospective study | 27.3 | 0 | 2 |
| Fluctuation of ELISA and skin biopsy results in individual inhabitants re-examined after several months in the endemic area of Guatemalan onchocerciasis | 27.3 | 0 | 2 |
| Nursing Mirror clinical forum. 3. Malignant skin conditions: squamous cell carcinoma | 27.3 | 0 | 2 |
| Aneuploidy in actinic keratosis and Bowen's disease—increased risk for invasive squamous cell carcinoma? | 27.3 | 0 | 2 |
| Lack of selective attendance of participants at skin cancer/melanoma screening clinics | 27.3 | 0 | 2 |
| Squamous cell carcinoma, basal cell carcinoma | 27.3 | 0 | 2 |
| 20-methylcholanthrene induced mouse skin cancer. Part 4: Study on the similarity between mouse skin cancer and human non-cicatric squamous cell carcinoma (author's transl) | 27.3 | 0 | 2 |
| Stereological analysis in oral precancerous lesions and squamous cell carcinoma | 27.3 | 0 | 2 |
| Factors favoring skin cancer and precancerous skin conditions | 27.3 | 0 | 2 |
| Clinical misdiagnosis of melanoma as well as squamous cell carcinoma masquerading as seborrheic keratosis | 27.3 | 0 | 2 |
| Selective loss of chondroitin 6-sulphate from basement membrane during progression from actinic keratosis to squamous cell carcinoma | 27.3 | 0 | 2 |
| Relations between basal cell carcinoma and actinic keratosis | 27.3 | 0 | 2 |
| Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma | 27.3 | 0 | 2 |
| Elderly skin care: principles of chronic wound care | 27.3 | 0 | 2 |
| Squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Mohs surgery for basal cell carcinoma on the face | 27.3 | 0 | 2 |
| Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer | 27.3 | 0 | 2 |
| Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis | 27.3 | 0 | 2 |
| Actinic keratosis is squamous cell carcinoma | 27.3 | 0 | 2 |
| Early melanoma detection. Skin cancer screening must become an insurance covered procedure | 27.3 | 0 | 2 |
| Pattern of use of skin care products in children with and without eczematous skin lesions | 27.3 | 0 | 2 |
| Micronucleus frequencies in exfoliated buccal cells in normal mucosa, precancerous lesions and squamous cell carcinoma | 27.3 | 0 | 2 |
| The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer | 27.3 | 0 | 2 |
| Spectrum of care treatment planning: application of the model in older adults | 27.3 | 0 | 2 |
| Nonmelanoma Skin Cancers and Mohs Surgery | 27.3 | 0 | 2 |
| Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation | 27.3 | 0 | 2 |
| Microscopic surgery (Mohs surgery) for skin cancers | 27.3 | 0 | 2 |
| DERM NMSC Validation Study | 27.3 | 0 | 2 |
| Improving the quality of care for older adults with mental disorders: the outcomes-based treatment planning system of the NH-Dartmouth Psychiatric Research Center | 27.3 | 0 | 2 |
| Frequency of pre‐existing actinic keratosis in cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Reduced human mismatch repair protein expression in the development of precancerous skin lesions to squamous cell carcinoma | 27.3 | 0 | 2 |
| Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor | 27.3 | 0 | 2 |
| Loss of heterozygosity in actinic keratosis, squamous cell carcinoma and sun-exposed normal-appearing skin in Japanese: difference between Japanese and Caucasians | 27.3 | 0 | 2 |
| Invasive cutaneous squamous cell carcinoma associated with actinic keratosis: a case with orbital invasion and meningeal infiltration | 27.3 | 0 | 2 |
| Inhibition of UV-induced p53 mutations and skin cancers by sunscreens: implication for skin cancer prevention | 27.3 | 0 | 2 |
| Observations on skin cancer in the Zwickau skin clinic | 27.3 | 0 | 2 |
| [Actinic keratosis seborrheic wart and nevus: three distinct cutaneous eyelid skin lesions in a single patient] | 27.3 | 0 | 2 |
| Risk group, skin lesion history, and sun sensitivity reliability in squamous cell skin cancer progression | 27.3 | 0 | 2 |
| [Nonsteroidal anti-inflammatory agents and the risk of actinic keratosis and squamous cell carcinoma] | 27.3 | 0 | 2 |
| Complications of systemic retinoid therapy in organ transplant recipients with squamous cell carcinoma | 27.3 | 0 | 2 |
| Micro-melanoma detection: a clinical study on 206 consecutive cases of pigmented skin lesions with a diameter < or = 3 mm | 27.3 | 0 | 2 |
| Seborrheic keratosis with in-situ squamous cell carcinoma changes | 27.3 | 0 | 2 |
| The diagnostic concordance of actinic keratosis and squamous cell carcinoma | 27.3 | 0 | 2 |
| Involvement of interleukin-10 promoter polymorphisms in nonmelanoma skin cancers-a case study in non-Caucasian skin cancer patients | 27.3 | 0 | 2 |
| Actinic keratosis. Early skin cancer? | 27.3 | 0 | 2 |
| PRb2/p130, p107 and p53 expression in precancerous lesions and squamous cell carcinoma of the uterine cervix | 27.3 | 0 | 2 |
| Diagnosis and treatment for squamous cell carcinoma and basal cell carcinoma of skin | 27.3 | 0 | 2 |
| Basal cell carcinoma. A skin cancer with a high cure rate | 27.3 | 0 | 2 |
| Every 10th person has actinic keratosis. Cold, light and cream prevent skin cancer | 27.3 | 0 | 2 |
| Clinical diagnosis of actinic keratosis identifies an elderly population at high risk of developing skin cancer | 27.3 | 0 | 2 |
| Therapeutic options for epithelial skin tumors. Actinic keratoses, Bowen disease, squamous cell carcinoma, and basal cell carcinoma | 27.3 | 0 | 2 |
| Actinic keratosis and development of cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Connective tissue growth factor expression in precancerous lesions of human esophageal epithelium and prognostic significance in esophageal squamous cell carcinoma | 27.3 | 0 | 2 |
| Mohs surgery in basal cell carcinoma on the face | 27.3 | 0 | 2 |
| Expression of Skp2 in cervical squamous cell carcinoma and precancerous lesions and its correlation with HPV16/18 infection | 27.3 | 0 | 2 |
| Non-melanoma skin cancer may raise your risk of other malignancies. Pay attention if you have had skin cancers; they could be a sign of increased risk of other, more serious cancers | 27.3 | 0 | 2 |
| The skin cancer you haven't heard about. It doesn't get as much attention as other skin cancers, but squamous cell cancer is common and serious | 27.3 | 0 | 2 |
| Prognosis of pretransplant melanoma | 27.3 | 0 | 2 |
| Melanoma in solid organ transplant recipients | 27.3 | 0 | 2 |
| The ABCs of skin care for wound care clinicians: dermatitis and eczema | 27.3 | 0 | 2 |
| MYC gene numerical aberrations in actinic keratosis and cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Squamous cell carcinoma on seborrheic keratosis | 27.3 | 0 | 2 |
| The keratin-14 expression in actinic keratosis and squamous cell carcinoma: is this a prognostic factor for tumor progression? | 27.3 | 0 | 2 |
| Actinic keratosis: precancer, squamous cell carcinoma, or marker of field cancerization? | 27.3 | 0 | 2 |
| Preventive services for older adults: recommendations and Medicare coverage | 27.3 | 0 | 2 |
| What can you tell me about Mohs surgery for skin cancer? | 27.3 | 0 | 2 |
| Actinic keratosis on a continuum with squamous cell carcinoma | 27.3 | 0 | 2 |
| Information from your family doctor. Skin cancer: basal cell and squamous cell carcinoma | 27.3 | 0 | 2 |
| Case of oculocutaneous albinism complicated with squamous cell carcinoma, Bowen's disease and actinic keratosis | 27.3 | 0 | 2 |
| An adolescent with a skin lesion. Squamous cell carcinoma of the skin secondary to voriconazole-induced photosensitivity | 27.3 | 0 | 2 |
| Understanding the main principles of skin care in older adults | 27.3 | 0 | 2 |
| Protect yourself from skin cancer. Reducing your sun exposure and performing periodic skin checks are the key steps | 27.3 | 0 | 2 |
| The real face of actinic keratosis: field of cancerisation and squamous cell carcinoma | 27.3 | 0 | 2 |
| Actinic keratosis: when is a skin biopsy necessary? | 27.3 | 0 | 2 |
| Comparison of facial predilection sites for cutaneous squamous cell carcinoma and actinic keratosis in Japanese patients | 27.3 | 0 | 2 |
| Pink Lesions | 27.3 | 0 | 2 |
| Cutaneous horn, actinic keratosis and squamous cell carcinoma. Presentation of a clinical case | 27.3 | 0 | 2 |
| Photodamage: all signs lead to actinic keratosis and early squamous cell carcinoma | 27.3 | 0 | 2 |
| Dermoscopy of Actinic Keratosis, Intraepidermal Carcinoma and Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Iatrogenic skin lesions: a prospective study in premature infants born at less than 33 weeks of amenorrhea at Besançon university hospital | 27.3 | 0 | 2 |
| Skin cancer screening campaigns in a Bucharest Dermatology Clinic | 27.3 | 0 | 2 |
| Advance care planning paves way for geriatrics nurses to support person-centered care for older adults | 27.3 | 0 | 2 |
| Increased expression of enhancer of Zeste Homolog 2 (EZH2) differentiates squamous cell carcinoma from normal skin and actinic keratosis | 27.3 | 0 | 2 |
| Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses | 27.3 | 0 | 2 |
| A glossary of terms to assist the recognition and diagnosis of skin conditions associated with lower-limb chronic oedema | 27.3 | 0 | 2 |
| Technique for histological control of surgical margins in lip cancer | 27.3 | 0 | 2 |
| Skin carotenoid levels are not associated with risk of nonmelanoma skin cancer: response to "Supplement use and the risk of cutaneous squamous cell carcinoma" | 27.3 | 0 | 2 |
| Malassezia growth on peritumoral skin after routine methyl-5-aminolevulinate photodynamic therapy for actinic keratosis and nonmelanoma skin cancer | 27.3 | 0 | 2 |
| Head and neck squamous cell carcinoma of unknown primary: Outcomes of a pre-defined institutional treatment policy in a region with a high prevalence of skin cancer | 27.3 | 0 | 2 |
| From the expert's office: squamous cell carcinoma or multiple actinic keratosis by natural UV-radiation - a new occupation disease | 27.3 | 0 | 2 |
| A Model To Identify Individuals at High Risk for Esophageal Squamous Cell Carcinoma and Precancerous Lesions in Regions of High Prevalence in China | 27.3 | 0 | 2 |
| Increasing Frequency of Seborrheic Keratosis Diagnoses as a Favorable Consequence of Teledermatology-Based Skin Cancer Screening: A Cross-sectional Study of 34,553 Patients | 27.3 | 0 | 2 |
| Reevaluating Mohs Surgery Appropriate Use Criteria for Primary Superficial Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Erratum to: Increasing Frequency of Seborrheic Keratosis Diagnoses as a Favorable Consequence of Teledermatology-Based Skin Cancer Screening: A Cross-sectional Study of 34,553 Patients | 27.3 | 0 | 2 |
| Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and malignant melanoma | 27.3 | 0 | 2 |
| Linking Neighborhood Context and Health in Community-Dwelling Older Adults in the Medicare Advantage Program | 27.3 | 0 | 2 |
| Performance of a computer-aided digital dermoscopic image analyzer for melanoma detection in 1,076 pigmented skin lesion biopsies | 27.3 | 0 | 2 |
| Rosettes in actinic keratosis and squamous cell carcinoma: distribution, association to other dermoscopic signs and description of the rosette pattern | 27.3 | 0 | 2 |
| Distinguishing between irritated seborrheic keratosis and squamous cell carcinoma in situ using BCL-2 and IMP3 immunohistochemistry | 27.3 | 0 | 2 |
| Mohs Surgery: Wound Care Considerations | 27.3 | 0 | 2 |
| Natural history of lesions suspicious for basal cell carcinoma in older adults in Ikaria, Greece | 27.3 | 0 | 2 |
| Detection of skin cancer odours using dogs: a step forward in melanoma detection training and research methodologies | 27.3 | 0 | 2 |
| Should medical students follow up on skin biopsy results? When education conflicts with patient privacy | 27.3 | 0 | 2 |
| A Retrospective Clinical View of Basal Cell Carcinoma and Squamous Cell Carcinoma in the Head and Neck Region: A Single Institution's Experience of 247 Cases over 19 Years | 27.3 | 0 | 2 |
| Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions | 27.3 | 0 | 2 |
| A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer | 27.3 | 0 | 2 |
| The new 8th edition of TNM staging and its implications for skin cancer: a review by the British Association of Dermatologists and the Royal College of Pathologists, U.K. | 27.3 | 0 | 2 |
| Needs and preferences of patients regarding basal cell carcinoma and cutaneous squamous cell carcinoma care: a qualitative focus group study | 27.3 | 0 | 2 |
| Rapid onset of squamous cell carcinoma in a thin skin graft donor site | 27.3 | 0 | 2 |
| Case of Japanese Hermansky-Pudlak syndrome patient with deeply invasive squamous cell carcinoma and multiple lesions of actinic keratosis on the face and neck | 27.3 | 0 | 2 |
| External auditory meatus and/or conchal bowl reconstruction with postauricular island flap in patients with Basal Cell Carcinoma or Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| A possible pitfall of Mohs surgery in collision tumor diagnosis: A case of a squamous cell carcinoma of the scalp overlying a metastatic breast lesion of the skull | 27.3 | 0 | 2 |
| Commentary on Patient Preferences for the Treatment of Basal Cell Carcinoma and Squamous Cell Carcinoma: A Mapping Review of Discrete Choice Experiments | 27.3 | 0 | 2 |
| Actinic Keratosis and Cutaneous Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Accuracy of dermoscopic criteria for the differential diagnosis between irritated seborrheic keratosis and squamous cell carcinoma | 27.3 | 0 | 2 |
| Magnetic Resonance Imaging Findings Differentiating Cutaneous Basal Cell Carcinoma from Squamous Cell Carcinoma in the Head and Neck Region | 27.3 | 0 | 2 |
| OVOL2-Mediated ZEB1 Downregulation May Prevent Promotion of Actinic Keratosis to Cutaneous Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Transformation of Seborrheic Keratosis into Bowenoid Actinic Keratosis via Three Steps of Histological Change in a Patient with Rheumatoid Arthritis Treated with Multiple Immunosuppressants | 27.3 | 0 | 2 |
| Awareness, knowledge, and attitude toward nonmelanoma skin cancer and actinic keratosis among the general population of western Saudi Arabia | 27.3 | 0 | 2 |
| S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma - short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators | 27.3 | 0 | 2 |
| Verrucous skin lesion caused by neuropathy misdiagnosed as squamous cell carcinoma and treated with amputation surgery | 27.3 | 0 | 2 |
| Usefulness of real-time elastography for diagnosing lymph node metastasis of skin cancer: does elastography potentially eliminate the need for sentinel lymph node biopsy in squamous cell carcinoma? | 27.3 | 0 | 2 |
| Actinic keratosis and squamous cell carcinoma of the elderly | 27.3 | 0 | 2 |
| Wound care in older adults | 27.3 | 0 | 2 |
| Granuloma faciale arising on a scar after Mohs surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| Commentary on Mohs Surgery as the Standard of Care for Nail Unit Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study | 27.3 | 0 | 2 |
| Early detection of melanoma: a consensus report from the Australian Skin and Skin Cancer Research Centre Melanoma Screening Summit | 27.3 | 0 | 2 |
| Definitive radiotherapy versus Mohs surgery for early stage nonmelanoma skin cancers: a multi-institutional retrospective comparison of local recurrence | 27.3 | 0 | 2 |
| Change in Sun-Protective Behavior After Dermatologic Surgery for Skin Cancer in High-Risk Patients | 27.3 | 0 | 2 |
| [Diagnosis and treatment of early esophageal squamous cell carcinoma and precancerous lesions] | 27.3 | 0 | 2 |
| An audit of pain scores with conventional and white light topical 5-methyl aminolaevulinic acid photodynamic therapy for superficial basal cell carcinoma and squamous cell carcinoma in situ | 27.3 | 0 | 2 |
| Social and Health-Related Factors Associated with Enrollment in Medicare Advantage Plans in Older Adults | 27.3 | 0 | 2 |
| Secondary Ossification Associated with Seborrheic Keratosis Adjacent to Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Understanding actinic keratosis to reduce squamous cell carcinoma incidence | 27.3 | 0 | 2 |
| Patient-centered management of actinic keratosis. Results of a multi-center clinical consensus analyzing non-melanoma skin cancer patient profiles and field-treatment strategies | 27.3 | 0 | 2 |
| Non-Melanoma Skin Cancer in Outdoor Workers: A Study on Actinic Keratosis in Italian Navy Personnel | 27.3 | 0 | 2 |
| Skin cancer in transplant recipients: Scientific retreat of the international immunosuppression and transplant skin cancer collaborative and skin care in organ transplant patients-Europe | 27.3 | 0 | 2 |
| Promoting Skin Care for Older Adults | 27.3 | 0 | 2 |
| Closing the Loop: Assuring That Skin Biopsy Results Are Received by Patients Following Hospital Discharge | 27.3 | 0 | 2 |
| Occurrence of newly discovered human polyomaviruses in skin of liver transplant recipients and their relation with squamous cell carcinoma in situ and actinic keratosis - a single-center cohort study | 27.3 | 0 | 2 |
| Basaloid tumors arising from seborrheic keratosis: Malignant basal cell carcinoma or benign basaloid follicular hamartomatous proliferation? | 27.3 | 0 | 2 |
| Application of Cyanoacrylate to Achieve Hemostasis in Elderly Patients with Inflamed, Friable, and Fragile Skin on Anticoagulation Following Dermatologic Surgery | 27.3 | 0 | 2 |
| Improvement in Fibromyalgia Symptoms and Skin Biopsy Results in Patients with Fibromyalgia Related Small Fiber Neuropathy | 27.3 | 0 | 2 |
| Psychosocial impact of skin biopsies in the setting of melanoma screening: a cross-sectional survey | 27.3 | 0 | 2 |
| Extremity nevus count is an independent risk factor for basal cell carcinoma and melanoma, but not squamous cell carcinoma | 27.3 | 0 | 2 |
| MTHFR C677T genetic polymorphism in combination with serum vitamin B2, B12 and aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and esophageal precancerous lesions: a case-control study | 27.3 | 0 | 2 |
| Comparison of oxidative stress on DNA, protein and lipids in patients with actinic keratosis, Bowen's disease and squamous cell carcinoma | 27.3 | 0 | 2 |
| Triple Collision Tumor Comprising Merkel Cell Carcinoma with an Unusual Immunophenotype, Squamous Cell Carcinoma In-Situ, and Basal Cell Carcinoma | 27.3 | 0 | 2 |
| S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) - short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational disease | 27.3 | 0 | 2 |
| Risk factors for local recurrence of basal cell carcinoma and cutaneous squamous cell carcinoma of the middle third of the face: a 15-year retrospective analysis based on a single centre | 27.3 | 0 | 2 |
| Comment on: "Mobile teledermatology for melanoma detection: Assessment of validity in the framework of a population-based skin cancer awareness campaign in northern Italy" | 27.3 | 0 | 2 |
| Reply to: "Comment on 'Mobile teledermatology for melanoma detection: Assessment of validity in the framework of a population-based skin cancer awareness campaign in northern Italy'" | 27.3 | 0 | 2 |
| Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma | 27.3 | 0 | 2 |
| Relevant Topical Skin Care Products for Prevention and Treatment of Aging Skin | 27.3 | 0 | 2 |
| Risk Factors Associated with Precancerous Lesions of Esophageal Squamous Cell Carcinoma: a Screening Study in a High Risk Chinese Population | 27.3 | 0 | 2 |
| Folliculocentric basaloid proliferation coexisting with basal cell carcinoma in Mohs Surgery: A potential cause of confusion | 27.3 | 0 | 2 |
| [Erratum to: Malignant collision tumor of the skin : Melanoma, squamous cell carcinoma and basal cell carcinoma] | 27.3 | 0 | 2 |
| Assessment of impact of a skin cancer education session on cosmetology students' knowledge and preparedness to assess future clients for skin lesions | 27.3 | 0 | 2 |
| Patient-Centered Care in Dermatologic Surgery: Practical Strategies to Improve the Patient Experience and Visit Satisfaction | 27.3 | 0 | 2 |